Age at Treatment=77.3;Gender=M;Phenotype=OBI_0000747;PreTreatment PSA=8;Tissue=Blood;ENA-CHECKLIST=ERC000026;
Age at Treatment=77.3;Gender=M;Phenotype=OBI_0000747;PreTreatment PSA=8;Tissue=Blood;ENA-CHECKLIST=ERC000026;
Age at Treatment=77.3;Gender=M;Phenotype=OBI_0000747;PreTreatment PSA=8;Tissue=Blood;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.50992471;gender=male;phenotype=OBI_0000747;PreTreatment PSA=1.97;Tissue=Blood;donor_id=CPCG0192;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.50992471;gender=male;phenotype=OBI_0000747;PreTreatment PSA=1.97;Tissue=Blood;donor_id=CPCG0192;ENA-CHECKLIST=ERC000026;
Age at Treatment=73.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.7;Sample=CPCG0486-B1;Tissue=Blood;donor_id=CPCG0486;ENA-CHECKLIST=ERC000026;
Age at Treatment=73.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.7;Sample=CPCG0486-B1;Tissue=Blood;donor_id=CPCG0486;ENA-CHECKLIST=ERC000026;
Age at Treatment=73.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.7;Sample=CPCG0486-B1;Tissue=Blood;donor_id=CPCG0486;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Sample=CPCG0487-B1;Tissue=Blood;donor_id=CPCG0487;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Sample=CPCG0487-B1;Tissue=Blood;donor_id=CPCG0487;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Sample=CPCG0487-B1;Tissue=Blood;donor_id=CPCG0487;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Sample=CPCG0487-B1;Tissue=Blood;donor_id=CPCG0487;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Sample=CPCG0487-B1;Tissue=Blood;donor_id=CPCG0487;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Sample=CPCG0487-B1;Tissue=Blood;donor_id=CPCG0487;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Sample=CPCG0487-B1;Tissue=Blood;donor_id=CPCG0487;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Sample=CPCG0487-B1;Tissue=Blood;donor_id=CPCG0487;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.4;Sample=CPCG0489-B1;Tissue=Blood;donor_id=CPCG0489;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.4;Sample=CPCG0489-B1;Tissue=Blood;donor_id=CPCG0489;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.4;Sample=CPCG0489-B1;Tissue=Blood;donor_id=CPCG0489;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.4;Sample=CPCG0489-B1;Tissue=Blood;donor_id=CPCG0489;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.4;Sample=CPCG0489-B1;Tissue=Blood;donor_id=CPCG0489;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.4;Sample=CPCG0489-B1;Tissue=Blood;donor_id=CPCG0489;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.4;Sample=CPCG0489-B1;Tissue=Blood;donor_id=CPCG0489;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.4;Sample=CPCG0489-B1;Tissue=Blood;donor_id=CPCG0489;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.0;Sample=CPCG0490-B1;Tissue=Blood;donor_id=CPCG0490;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.0;Sample=CPCG0490-B1;Tissue=Blood;donor_id=CPCG0490;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.0;Sample=CPCG0490-B1;Tissue=Blood;donor_id=CPCG0490;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.0;Sample=CPCG0490-B1;Tissue=Blood;donor_id=CPCG0490;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.0;Sample=CPCG0490-B1;Tissue=Blood;donor_id=CPCG0490;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.0;Sample=CPCG0490-B1;Tissue=Blood;donor_id=CPCG0490;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.0;Sample=CPCG0490-B1;Tissue=Blood;donor_id=CPCG0490;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.0;Sample=CPCG0490-B1;Tissue=Blood;donor_id=CPCG0490;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.0;Sample=CPCG0492-B1;Tissue=Blood;donor_id=CPCG0492;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.0;Sample=CPCG0492-B1;Tissue=Blood;donor_id=CPCG0492;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.0;Sample=CPCG0492-B1;Tissue=Blood;donor_id=CPCG0492;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.0;Sample=CPCG0492-B1;Tissue=Blood;donor_id=CPCG0492;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.0;Sample=CPCG0492-B1;Tissue=Blood;donor_id=CPCG0492;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.0;Sample=CPCG0492-B1;Tissue=Blood;donor_id=CPCG0492;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.0;Sample=CPCG0492-B1;Tissue=Blood;donor_id=CPCG0492;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.0;Sample=CPCG0492-B1;Tissue=Blood;donor_id=CPCG0492;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.0;Sample=CPCG0492-B1;Tissue=Blood;donor_id=CPCG0492;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.0;Sample=CPCG0492-B1;Tissue=Blood;donor_id=CPCG0492;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.0;Sample=CPCG0492-B1;Tissue=Blood;donor_id=CPCG0492;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.0;Sample=CPCG0492-B1;Tissue=Blood;donor_id=CPCG0492;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.0;Sample=CPCG0492-B1;Tissue=Blood;donor_id=CPCG0492;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.0;Sample=CPCG0492-B1;Tissue=Blood;donor_id=CPCG0492;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.0;Sample=CPCG0492-B1;Tissue=Blood;donor_id=CPCG0492;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.0;Sample=CPCG0492-B1;Tissue=Blood;donor_id=CPCG0492;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.0;Sample=CPCG0492-B1;Tissue=Blood;donor_id=CPCG0492;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.0;Sample=CPCG0492-B1;Tissue=Blood;donor_id=CPCG0492;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.6;Sample=CPCG0493-B1;Tissue=Blood;donor_id=CPCG0493;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.6;Sample=CPCG0493-B1;Tissue=Blood;donor_id=CPCG0493;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.6;Sample=CPCG0493-B1;Tissue=Blood;donor_id=CPCG0493;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.6;Sample=CPCG0493-B1;Tissue=Blood;donor_id=CPCG0493;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.6;Sample=CPCG0493-B1;Tissue=Blood;donor_id=CPCG0493;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.6;Sample=CPCG0493-B1;Tissue=Blood;donor_id=CPCG0493;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.6;Sample=CPCG0493-B1;Tissue=Blood;donor_id=CPCG0493;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.6;Sample=CPCG0493-B1;Tissue=Blood;donor_id=CPCG0493;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.9;Sample=CPCG0496-B1;Tissue=Blood;donor_id=CPCG0496;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.9;Sample=CPCG0496-B1;Tissue=Blood;donor_id=CPCG0496;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.9;Sample=CPCG0496-B1;Tissue=Blood;donor_id=CPCG0496;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.9;Sample=CPCG0496-B1;Tissue=Blood;donor_id=CPCG0496;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.9;Sample=CPCG0496-B1;Tissue=Blood;donor_id=CPCG0496;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.9;Sample=CPCG0496-B1;Tissue=Blood;donor_id=CPCG0496;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.9;Sample=CPCG0496-B1;Tissue=Blood;donor_id=CPCG0496;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.9;Sample=CPCG0496-B1;Tissue=Blood;donor_id=CPCG0496;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.7;Sample=CPCG0498-B1;Tissue=Blood;donor_id=CPCG0498;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.7;Sample=CPCG0498-B1;Tissue=Blood;donor_id=CPCG0498;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.7;Sample=CPCG0498-B1;Tissue=Blood;donor_id=CPCG0498;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.7;Sample=CPCG0498-B1;Tissue=Blood;donor_id=CPCG0498;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.7;Sample=CPCG0498-B1;Tissue=Blood;donor_id=CPCG0498;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.7;Sample=CPCG0498-B1;Tissue=Blood;donor_id=CPCG0498;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.7;Sample=CPCG0498-B1;Tissue=Blood;donor_id=CPCG0498;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.7;Sample=CPCG0498-B1;Tissue=Blood;donor_id=CPCG0498;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=14.0;Sample=CPCG0499-B1;Tissue=Blood;donor_id=CPCG0499;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=14.0;Sample=CPCG0499-B1;Tissue=Blood;donor_id=CPCG0499;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=14.0;Sample=CPCG0499-B1;Tissue=Blood;donor_id=CPCG0499;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=14.0;Sample=CPCG0499-B1;Tissue=Blood;donor_id=CPCG0499;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=14.0;Sample=CPCG0499-B1;Tissue=Blood;donor_id=CPCG0499;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=14.0;Sample=CPCG0499-B1;Tissue=Blood;donor_id=CPCG0499;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=14.0;Sample=CPCG0499-B1;Tissue=Blood;donor_id=CPCG0499;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=14.0;Sample=CPCG0499-B1;Tissue=Blood;donor_id=CPCG0499;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.4;Sample=CPCG0500-B1;Tissue=Blood;donor_id=CPCG0500;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.4;Sample=CPCG0500-B1;Tissue=Blood;donor_id=CPCG0500;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.4;Sample=CPCG0500-B1;Tissue=Blood;donor_id=CPCG0500;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.4;Sample=CPCG0500-B1;Tissue=Blood;donor_id=CPCG0500;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.4;Sample=CPCG0500-B1;Tissue=Blood;donor_id=CPCG0500;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.4;Sample=CPCG0500-B1;Tissue=Blood;donor_id=CPCG0500;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.4;Sample=CPCG0500-B1;Tissue=Blood;donor_id=CPCG0500;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.4;Sample=CPCG0500-B1;Tissue=Blood;donor_id=CPCG0500;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Sample=CPCG0502-B1;Tissue=Blood;donor_id=CPCG0502;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Sample=CPCG0502-B1;Tissue=Blood;donor_id=CPCG0502;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Sample=CPCG0502-B1;Tissue=Blood;donor_id=CPCG0502;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Sample=CPCG0502-B1;Tissue=Blood;donor_id=CPCG0502;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Sample=CPCG0502-B1;Tissue=Blood;donor_id=CPCG0502;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Sample=CPCG0502-B1;Tissue=Blood;donor_id=CPCG0502;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Sample=CPCG0502-B1;Tissue=Blood;donor_id=CPCG0502;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Sample=CPCG0502-B1;Tissue=Blood;donor_id=CPCG0502;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.0;Sample=CPCG0503-B1;Tissue=Blood;donor_id=CPCG0503;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.0;Sample=CPCG0503-B1;Tissue=Blood;donor_id=CPCG0503;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.0;Sample=CPCG0503-B1;Tissue=Blood;donor_id=CPCG0503;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.0;Sample=CPCG0503-B1;Tissue=Blood;donor_id=CPCG0503;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.0;Sample=CPCG0503-B1;Tissue=Blood;donor_id=CPCG0503;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.0;Sample=CPCG0503-B1;Tissue=Blood;donor_id=CPCG0503;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.0;Sample=CPCG0503-B1;Tissue=Blood;donor_id=CPCG0503;ENA-CHECKLIST=ERC000026;
Age at Treatment=65.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.0;Sample=CPCG0503-B1;Tissue=Blood;donor_id=CPCG0503;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.2;Sample=CPCG0504-B1;Tissue=Blood;donor_id=CPCG0504;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.2;Sample=CPCG0504-B1;Tissue=Blood;donor_id=CPCG0504;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.2;Sample=CPCG0504-B1;Tissue=Blood;donor_id=CPCG0504;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.2;Sample=CPCG0504-B1;Tissue=Blood;donor_id=CPCG0504;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.2;Sample=CPCG0504-B1;Tissue=Blood;donor_id=CPCG0504;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.2;Sample=CPCG0504-B1;Tissue=Blood;donor_id=CPCG0504;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.2;Sample=CPCG0504-B1;Tissue=Blood;donor_id=CPCG0504;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.2;Sample=CPCG0504-B1;Tissue=Blood;donor_id=CPCG0504;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.1;Sample=CPCG0507-B1;Tissue=Blood;donor_id=CPCG0507;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.1;Sample=CPCG0507-B1;Tissue=Blood;donor_id=CPCG0507;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.1;Sample=CPCG0507-B1;Tissue=Blood;donor_id=CPCG0507;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.1;Sample=CPCG0507-B1;Tissue=Blood;donor_id=CPCG0507;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.1;Sample=CPCG0507-B1;Tissue=Blood;donor_id=CPCG0507;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.1;Sample=CPCG0507-B1;Tissue=Blood;donor_id=CPCG0507;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.1;Sample=CPCG0507-B1;Tissue=Blood;donor_id=CPCG0507;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.1;Sample=CPCG0507-B1;Tissue=Blood;donor_id=CPCG0507;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.2;Sample=CPCG0508-B1;Tissue=Blood;donor_id=CPCG0508;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.2;Sample=CPCG0508-B1;Tissue=Blood;donor_id=CPCG0508;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.2;Sample=CPCG0508-B1;Tissue=Blood;donor_id=CPCG0508;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.2;Sample=CPCG0508-B1;Tissue=Blood;donor_id=CPCG0508;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.2;Sample=CPCG0508-B1;Tissue=Blood;donor_id=CPCG0508;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.2;Sample=CPCG0508-B1;Tissue=Blood;donor_id=CPCG0508;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.2;Sample=CPCG0508-B1;Tissue=Blood;donor_id=CPCG0508;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.2;Sample=CPCG0508-B1;Tissue=Blood;donor_id=CPCG0508;ENA-CHECKLIST=ERC000026;
Age at Treatment=73.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0509-B1;Tissue=Blood;donor_id=CPCG0509;ENA-CHECKLIST=ERC000026;
Age at Treatment=73.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0509-B1;Tissue=Blood;donor_id=CPCG0509;ENA-CHECKLIST=ERC000026;
Age at Treatment=73.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0509-B1;Tissue=Blood;donor_id=CPCG0509;ENA-CHECKLIST=ERC000026;
Age at Treatment=73.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0509-B1;Tissue=Blood;donor_id=CPCG0509;ENA-CHECKLIST=ERC000026;
Age at Treatment=73.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0509-B1;Tissue=Blood;donor_id=CPCG0509;ENA-CHECKLIST=ERC000026;
Age at Treatment=73.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0509-B1;Tissue=Blood;donor_id=CPCG0509;ENA-CHECKLIST=ERC000026;
Age at Treatment=73.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0509-B1;Tissue=Blood;donor_id=CPCG0509;ENA-CHECKLIST=ERC000026;
Age at Treatment=73.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0509-B1;Tissue=Blood;donor_id=CPCG0509;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.2;Sample=CPCG0514-B1;Tissue=Blood;donor_id=CPCG0514;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.2;Sample=CPCG0514-B1;Tissue=Blood;donor_id=CPCG0514;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.2;Sample=CPCG0514-B1;Tissue=Blood;donor_id=CPCG0514;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.2;Sample=CPCG0514-B1;Tissue=Blood;donor_id=CPCG0514;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.2;Sample=CPCG0514-B1;Tissue=Blood;donor_id=CPCG0514;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.2;Sample=CPCG0514-B1;Tissue=Blood;donor_id=CPCG0514;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.2;Sample=CPCG0514-B1;Tissue=Blood;donor_id=CPCG0514;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.2;Sample=CPCG0514-B1;Tissue=Blood;donor_id=CPCG0514;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.0;Sample=CPCG0519-B1;Tissue=Blood;donor_id=CPCG0519;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.0;Sample=CPCG0519-B1;Tissue=Blood;donor_id=CPCG0519;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.0;Sample=CPCG0519-B1;Tissue=Blood;donor_id=CPCG0519;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.0;Sample=CPCG0519-B1;Tissue=Blood;donor_id=CPCG0519;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.0;Sample=CPCG0519-B1;Tissue=Blood;donor_id=CPCG0519;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.0;Sample=CPCG0519-B1;Tissue=Blood;donor_id=CPCG0519;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.0;Sample=CPCG0519-B1;Tissue=Blood;donor_id=CPCG0519;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.0;Sample=CPCG0519-B1;Tissue=Blood;donor_id=CPCG0519;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.2;Sample=CPCG0520-B1;Tissue=Blood;donor_id=CPCG0520;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.2;Sample=CPCG0520-B1;Tissue=Blood;donor_id=CPCG0520;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.2;Sample=CPCG0520-B1;Tissue=Blood;donor_id=CPCG0520;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.2;Sample=CPCG0520-B1;Tissue=Blood;donor_id=CPCG0520;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.2;Sample=CPCG0520-B1;Tissue=Blood;donor_id=CPCG0520;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.2;Sample=CPCG0520-B1;Tissue=Blood;donor_id=CPCG0520;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.2;Sample=CPCG0520-B1;Tissue=Blood;donor_id=CPCG0520;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.2;Sample=CPCG0520-B1;Tissue=Blood;donor_id=CPCG0520;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.1;Sample=CPCG0521-B1;Tissue=Blood;donor_id=CPCG0521;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.1;Sample=CPCG0521-B1;Tissue=Blood;donor_id=CPCG0521;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.1;Sample=CPCG0521-B1;Tissue=Blood;donor_id=CPCG0521;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.1;Sample=CPCG0521-B1;Tissue=Blood;donor_id=CPCG0521;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.1;Sample=CPCG0521-B1;Tissue=Blood;donor_id=CPCG0521;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.1;Sample=CPCG0521-B1;Tissue=Blood;donor_id=CPCG0521;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.1;Sample=CPCG0521-B1;Tissue=Blood;donor_id=CPCG0521;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.1;Sample=CPCG0521-B1;Tissue=Blood;donor_id=CPCG0521;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0522-B1;Tissue=Blood;donor_id=CPCG0522;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0522-B1;Tissue=Blood;donor_id=CPCG0522;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0522-B1;Tissue=Blood;donor_id=CPCG0522;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0522-B1;Tissue=Blood;donor_id=CPCG0522;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0522-B1;Tissue=Blood;donor_id=CPCG0522;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0522-B1;Tissue=Blood;donor_id=CPCG0522;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0522-B1;Tissue=Blood;donor_id=CPCG0522;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0522-B1;Tissue=Blood;donor_id=CPCG0522;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.4;Sample=CPCG0523-B1;Tissue=Blood;donor_id=CPCG0523;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.4;Sample=CPCG0523-B1;Tissue=Blood;donor_id=CPCG0523;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.4;Sample=CPCG0523-B1;Tissue=Blood;donor_id=CPCG0523;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.4;Sample=CPCG0523-B1;Tissue=Blood;donor_id=CPCG0523;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.4;Sample=CPCG0523-B1;Tissue=Blood;donor_id=CPCG0523;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.4;Sample=CPCG0523-B1;Tissue=Blood;donor_id=CPCG0523;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.4;Sample=CPCG0523-B1;Tissue=Blood;donor_id=CPCG0523;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.4;Sample=CPCG0523-B1;Tissue=Blood;donor_id=CPCG0523;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.8;Sample=CPCG0524-B1;Tissue=Blood;donor_id=CPCG0524;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.8;Sample=CPCG0524-B1;Tissue=Blood;donor_id=CPCG0524;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.8;Sample=CPCG0524-B1;Tissue=Blood;donor_id=CPCG0524;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.8;Sample=CPCG0524-B1;Tissue=Blood;donor_id=CPCG0524;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.8;Sample=CPCG0524-B1;Tissue=Blood;donor_id=CPCG0524;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.8;Sample=CPCG0524-B1;Tissue=Blood;donor_id=CPCG0524;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.8;Sample=CPCG0524-B1;Tissue=Blood;donor_id=CPCG0524;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.8;Sample=CPCG0524-B1;Tissue=Blood;donor_id=CPCG0524;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.0;Sample=CPCG0525-B1;Tissue=Blood;donor_id=CPCG0525;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.0;Sample=CPCG0525-B1;Tissue=Blood;donor_id=CPCG0525;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.0;Sample=CPCG0525-B1;Tissue=Blood;donor_id=CPCG0525;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.0;Sample=CPCG0525-B1;Tissue=Blood;donor_id=CPCG0525;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.0;Sample=CPCG0525-B1;Tissue=Blood;donor_id=CPCG0525;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.0;Sample=CPCG0525-B1;Tissue=Blood;donor_id=CPCG0525;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.0;Sample=CPCG0525-B1;Tissue=Blood;donor_id=CPCG0525;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.0;Sample=CPCG0525-B1;Tissue=Blood;donor_id=CPCG0525;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.0;Sample=CPCG0525-B1;Tissue=Blood;donor_id=CPCG0525;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.0;Sample=CPCG0525-B1;Tissue=Blood;donor_id=CPCG0525;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.0;Sample=CPCG0525-B1;Tissue=Blood;donor_id=CPCG0525;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.0;Sample=CPCG0525-B1;Tissue=Blood;donor_id=CPCG0525;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.0;Sample=CPCG0525-B1;Tissue=Blood;donor_id=CPCG0525;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.5;Sample=CPCG0526-B1;Tissue=Blood;donor_id=CPCG0526;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.5;Sample=CPCG0526-B1;Tissue=Blood;donor_id=CPCG0526;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.5;Sample=CPCG0526-B1;Tissue=Blood;donor_id=CPCG0526;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.5;Sample=CPCG0526-B1;Tissue=Blood;donor_id=CPCG0526;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.5;Sample=CPCG0526-B1;Tissue=Blood;donor_id=CPCG0526;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.5;Sample=CPCG0526-B1;Tissue=Blood;donor_id=CPCG0526;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.5;Sample=CPCG0526-B1;Tissue=Blood;donor_id=CPCG0526;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.5;Sample=CPCG0526-B1;Tissue=Blood;donor_id=CPCG0526;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.1;Sample=CPCG0527-B1;Tissue=Blood;donor_id=CPCG0527;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.1;Sample=CPCG0527-B1;Tissue=Blood;donor_id=CPCG0527;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.1;Sample=CPCG0527-B1;Tissue=Blood;donor_id=CPCG0527;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.1;Sample=CPCG0527-B1;Tissue=Blood;donor_id=CPCG0527;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.1;Sample=CPCG0527-B1;Tissue=Blood;donor_id=CPCG0527;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.1;Sample=CPCG0527-B1;Tissue=Blood;donor_id=CPCG0527;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.1;Sample=CPCG0527-B1;Tissue=Blood;donor_id=CPCG0527;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.1;Sample=CPCG0527-B1;Tissue=Blood;donor_id=CPCG0527;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.7;Sample=CPCG0528-B1;Tissue=Blood;donor_id=CPCG0528;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.7;Sample=CPCG0528-B1;Tissue=Blood;donor_id=CPCG0528;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.7;Sample=CPCG0528-B1;Tissue=Blood;donor_id=CPCG0528;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.7;Sample=CPCG0528-B1;Tissue=Blood;donor_id=CPCG0528;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.7;Sample=CPCG0528-B1;Tissue=Blood;donor_id=CPCG0528;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.7;Sample=CPCG0528-B1;Tissue=Blood;donor_id=CPCG0528;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.7;Sample=CPCG0528-B1;Tissue=Blood;donor_id=CPCG0528;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.7;Sample=CPCG0528-B1;Tissue=Blood;donor_id=CPCG0528;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.8;Sample=CPCG0529-B1;Tissue=Blood;donor_id=CPCG0529;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.8;Sample=CPCG0529-B1;Tissue=Blood;donor_id=CPCG0529;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.8;Sample=CPCG0529-B1;Tissue=Blood;donor_id=CPCG0529;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.8;Sample=CPCG0529-B1;Tissue=Blood;donor_id=CPCG0529;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.8;Sample=CPCG0529-B1;Tissue=Blood;donor_id=CPCG0529;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.8;Sample=CPCG0529-B1;Tissue=Blood;donor_id=CPCG0529;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.8;Sample=CPCG0529-B1;Tissue=Blood;donor_id=CPCG0529;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.8;Sample=CPCG0529-B1;Tissue=Blood;donor_id=CPCG0529;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=18.0;Sample=CPCG0531-B1;Tissue=Blood;donor_id=CPCG0531;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=18.0;Sample=CPCG0531-B1;Tissue=Blood;donor_id=CPCG0531;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=18.0;Sample=CPCG0531-B1;Tissue=Blood;donor_id=CPCG0531;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=18.0;Sample=CPCG0531-B1;Tissue=Blood;donor_id=CPCG0531;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=18.0;Sample=CPCG0531-B1;Tissue=Blood;donor_id=CPCG0531;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=18.0;Sample=CPCG0531-B1;Tissue=Blood;donor_id=CPCG0531;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=18.0;Sample=CPCG0531-B1;Tissue=Blood;donor_id=CPCG0531;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=18.0;Sample=CPCG0531-B1;Tissue=Blood;donor_id=CPCG0531;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.9;Sample=CPCG0532-B1;Tissue=Blood;donor_id=CPCG0532;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.9;Sample=CPCG0532-B1;Tissue=Blood;donor_id=CPCG0532;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.9;Sample=CPCG0532-B1;Tissue=Blood;donor_id=CPCG0532;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.9;Sample=CPCG0532-B1;Tissue=Blood;donor_id=CPCG0532;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.9;Sample=CPCG0532-B1;Tissue=Blood;donor_id=CPCG0532;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.9;Sample=CPCG0532-B1;Tissue=Blood;donor_id=CPCG0532;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.9;Sample=CPCG0532-B1;Tissue=Blood;donor_id=CPCG0532;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.9;Sample=CPCG0532-B1;Tissue=Blood;donor_id=CPCG0532;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.5;Sample=CPCG0533-B1;Tissue=Blood;donor_id=CPCG0533;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.5;Sample=CPCG0533-B1;Tissue=Blood;donor_id=CPCG0533;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.5;Sample=CPCG0533-B1;Tissue=Blood;donor_id=CPCG0533;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.5;Sample=CPCG0533-B1;Tissue=Blood;donor_id=CPCG0533;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.5;Sample=CPCG0533-B1;Tissue=Blood;donor_id=CPCG0533;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.5;Sample=CPCG0533-B1;Tissue=Blood;donor_id=CPCG0533;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.5;Sample=CPCG0533-B1;Tissue=Blood;donor_id=CPCG0533;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.5;Sample=CPCG0533-B1;Tissue=Blood;donor_id=CPCG0533;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=18.0;Sample=CPCG0534-B1;Tissue=Blood;donor_id=CPCG0534;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=18.0;Sample=CPCG0534-B1;Tissue=Blood;donor_id=CPCG0534;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=18.0;Sample=CPCG0534-B1;Tissue=Blood;donor_id=CPCG0534;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=18.0;Sample=CPCG0534-B1;Tissue=Blood;donor_id=CPCG0534;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=18.0;Sample=CPCG0534-B1;Tissue=Blood;donor_id=CPCG0534;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=18.0;Sample=CPCG0534-B1;Tissue=Blood;donor_id=CPCG0534;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=18.0;Sample=CPCG0534-B1;Tissue=Blood;donor_id=CPCG0534;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=18.0;Sample=CPCG0534-B1;Tissue=Blood;donor_id=CPCG0534;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.3;Sample=CPCG0537-B1;Tissue=Blood;donor_id=CPCG0537;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.3;Sample=CPCG0537-B1;Tissue=Blood;donor_id=CPCG0537;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.3;Sample=CPCG0537-B1;Tissue=Blood;donor_id=CPCG0537;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.3;Sample=CPCG0537-B1;Tissue=Blood;donor_id=CPCG0537;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.3;Sample=CPCG0537-B1;Tissue=Blood;donor_id=CPCG0537;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.3;Sample=CPCG0537-B1;Tissue=Blood;donor_id=CPCG0537;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.3;Sample=CPCG0537-B1;Tissue=Blood;donor_id=CPCG0537;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.7;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.3;Sample=CPCG0537-B1;Tissue=Blood;donor_id=CPCG0537;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.4;Sample=CPCG0539-B1;Tissue=Blood;donor_id=CPCG0539;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.4;Sample=CPCG0539-B1;Tissue=Blood;donor_id=CPCG0539;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.4;Sample=CPCG0539-B1;Tissue=Blood;donor_id=CPCG0539;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.4;Sample=CPCG0539-B1;Tissue=Blood;donor_id=CPCG0539;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.4;Sample=CPCG0539-B1;Tissue=Blood;donor_id=CPCG0539;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.4;Sample=CPCG0539-B1;Tissue=Blood;donor_id=CPCG0539;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.4;Sample=CPCG0539-B1;Tissue=Blood;donor_id=CPCG0539;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.4;Sample=CPCG0539-B1;Tissue=Blood;donor_id=CPCG0539;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.9;Sample=CPCG0540-B1;Tissue=Blood;donor_id=CPCG0540;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.9;Sample=CPCG0540-B1;Tissue=Blood;donor_id=CPCG0540;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.9;Sample=CPCG0540-B1;Tissue=Blood;donor_id=CPCG0540;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.9;Sample=CPCG0540-B1;Tissue=Blood;donor_id=CPCG0540;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.9;Sample=CPCG0540-B1;Tissue=Blood;donor_id=CPCG0540;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.9;Sample=CPCG0540-B1;Tissue=Blood;donor_id=CPCG0540;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.9;Sample=CPCG0540-B1;Tissue=Blood;donor_id=CPCG0540;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.9;Sample=CPCG0540-B1;Tissue=Blood;donor_id=CPCG0540;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Sample=CPCG0545-B1;Tissue=Blood;donor_id=CPCG0545;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Sample=CPCG0545-B1;Tissue=Blood;donor_id=CPCG0545;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Sample=CPCG0545-B1;Tissue=Blood;donor_id=CPCG0545;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Sample=CPCG0545-B1;Tissue=Blood;donor_id=CPCG0545;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Sample=CPCG0545-B1;Tissue=Blood;donor_id=CPCG0545;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Sample=CPCG0545-B1;Tissue=Blood;donor_id=CPCG0545;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Sample=CPCG0545-B1;Tissue=Blood;donor_id=CPCG0545;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Sample=CPCG0545-B1;Tissue=Blood;donor_id=CPCG0545;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.15947981;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.84;Tissue=Blood;donor_id=CPCG0547;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.15947981;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.84;Tissue=Blood;donor_id=CPCG0547;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.66187543;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.59;Tissue=Blood;donor_id=CPCG0550;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.66187543;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.59;Tissue=Blood;donor_id=CPCG0550;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.66187543;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.59;Tissue=Blood;donor_id=CPCG0550;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.66187543;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.59;Tissue=Blood;donor_id=CPCG0550;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.66187543;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.59;Tissue=Blood;donor_id=CPCG0550;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.66187543;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.59;Tissue=Blood;donor_id=CPCG0550;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.66187543;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.59;Tissue=Blood;donor_id=CPCG0550;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.13483915;gender=male;phenotype=OBI_0000747;PreTreatment PSA=5.2;Tissue=Blood;donor_id=CPCG0551;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.13483915;gender=male;phenotype=OBI_0000747;PreTreatment PSA=5.2;Tissue=Blood;donor_id=CPCG0551;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.13483915;gender=male;phenotype=OBI_0000747;PreTreatment PSA=5.2;Tissue=Blood;donor_id=CPCG0551;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.13483915;gender=male;phenotype=OBI_0000747;PreTreatment PSA=5.2;Tissue=Blood;donor_id=CPCG0551;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.13483915;gender=male;phenotype=OBI_0000747;PreTreatment PSA=5.2;Tissue=Blood;donor_id=CPCG0551;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.13483915;gender=male;phenotype=OBI_0000747;PreTreatment PSA=5.2;Tissue=Blood;donor_id=CPCG0551;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.13483915;gender=male;phenotype=OBI_0000747;PreTreatment PSA=5.2;Tissue=Blood;donor_id=CPCG0551;ENA-CHECKLIST=ERC000026;
Age at Treatment=45.52498289;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.74;Tissue=Blood;donor_id=CPCG0557;ENA-CHECKLIST=ERC000026;
Age at Treatment=45.52498289;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.74;Tissue=Blood;donor_id=CPCG0557;ENA-CHECKLIST=ERC000026;
Age at Treatment=45.52498289;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.74;Tissue=Blood;donor_id=CPCG0557;ENA-CHECKLIST=ERC000026;
Age at Treatment=45.52498289;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.74;Tissue=Blood;donor_id=CPCG0557;ENA-CHECKLIST=ERC000026;
Age at Treatment=45.52498289;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.74;Tissue=Blood;donor_id=CPCG0557;ENA-CHECKLIST=ERC000026;
Age at Treatment=45.52498289;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.74;Tissue=Blood;donor_id=CPCG0557;ENA-CHECKLIST=ERC000026;
Age at Treatment=45.52498289;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.74;Tissue=Blood;donor_id=CPCG0557;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2881588;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.2;Tissue=Blood;donor_id=CPCG0559;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2881588;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.2;Tissue=Blood;donor_id=CPCG0559;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2881588;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.2;Tissue=Blood;donor_id=CPCG0559;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2881588;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.2;Tissue=Blood;donor_id=CPCG0559;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2881588;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.2;Tissue=Blood;donor_id=CPCG0559;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2881588;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.2;Tissue=Blood;donor_id=CPCG0559;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2881588;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.2;Tissue=Blood;donor_id=CPCG0559;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.81382615;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.6;Tissue=Blood;donor_id=CPCG0560;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.81382615;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.6;Tissue=Blood;donor_id=CPCG0560;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.81382615;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.6;Tissue=Blood;donor_id=CPCG0560;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.81382615;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.6;Tissue=Blood;donor_id=CPCG0560;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.81382615;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.6;Tissue=Blood;donor_id=CPCG0560;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.81382615;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.6;Tissue=Blood;donor_id=CPCG0560;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.81382615;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.6;Tissue=Blood;donor_id=CPCG0560;ENA-CHECKLIST=ERC000026;
Age at Treatment=56.24640657;gender=male;phenotype=OBI_0000747;PreTreatment PSA=5.3;Tissue=Blood;donor_id=CPCG0561;ENA-CHECKLIST=ERC000026;
Age at Treatment=56.24640657;gender=male;phenotype=OBI_0000747;PreTreatment PSA=5.3;Tissue=Blood;donor_id=CPCG0561;ENA-CHECKLIST=ERC000026;
Age at Treatment=56.24640657;gender=male;phenotype=OBI_0000747;PreTreatment PSA=5.3;Tissue=Blood;donor_id=CPCG0561;ENA-CHECKLIST=ERC000026;
Age at Treatment=56.24640657;gender=male;phenotype=OBI_0000747;PreTreatment PSA=5.3;Tissue=Blood;donor_id=CPCG0561;ENA-CHECKLIST=ERC000026;
Age at Treatment=56.24640657;gender=male;phenotype=OBI_0000747;PreTreatment PSA=5.3;Tissue=Blood;donor_id=CPCG0561;ENA-CHECKLIST=ERC000026;
Age at Treatment=56.24640657;gender=male;phenotype=OBI_0000747;PreTreatment PSA=5.3;Tissue=Blood;donor_id=CPCG0561;ENA-CHECKLIST=ERC000026;
Age at Treatment=56.24640657;gender=male;phenotype=OBI_0000747;PreTreatment PSA=5.3;Tissue=Blood;donor_id=CPCG0561;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.0;Sample=CPCG0525-B1;Tissue=Blood;donor_id=CPCG0525;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.59685147;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.1;Tissue=Blood;donor_id=CPCG0591;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.64750171;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.7;Tissue=Blood;donor_id=CPCG0562;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.64750171;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.7;Tissue=Blood;donor_id=CPCG0562;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.64750171;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.7;Tissue=Blood;donor_id=CPCG0562;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.64750171;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.7;Tissue=Blood;donor_id=CPCG0562;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.64750171;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.7;Tissue=Blood;donor_id=CPCG0562;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.64750171;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.7;Tissue=Blood;donor_id=CPCG0562;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.64750171;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.7;Tissue=Blood;donor_id=CPCG0562;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.6;Sample=CPCG0563-B1;Tissue=Blood;donor_id=CPCG0563;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.6;Sample=CPCG0563-B1;Tissue=Blood;donor_id=CPCG0563;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.6;Sample=CPCG0563-B1;Tissue=Blood;donor_id=CPCG0563;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.6;Sample=CPCG0563-B1;Tissue=Blood;donor_id=CPCG0563;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.6;Sample=CPCG0563-B1;Tissue=Blood;donor_id=CPCG0563;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.6;Sample=CPCG0563-B1;Tissue=Blood;donor_id=CPCG0563;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.6;Sample=CPCG0563-B1;Tissue=Blood;donor_id=CPCG0563;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.8;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.6;Sample=CPCG0563-B1;Tissue=Blood;donor_id=CPCG0563;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.6;Tissue=Blood;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.6;Tissue=Blood;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.6;Tissue=Blood;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.6;Tissue=Blood;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.6;Tissue=Blood;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.6;Tissue=Blood;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.6;Tissue=Blood;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.6;Tissue=Blood;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10.6;Tissue=Blood;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10.6;Tissue=Blood;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10.6;Tissue=Blood;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10.6;Tissue=Blood;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10.6;Tissue=Blood;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10.6;Tissue=Blood;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10.6;Tissue=Blood;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10.6;Tissue=Blood;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.6;Tissue=Blood;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.6;Tissue=Blood;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.6;Tissue=Blood;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.6;Tissue=Blood;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.6;Tissue=Blood;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.6;Tissue=Blood;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.6;Tissue=Blood;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.6;Tissue=Blood;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0568-B1;Tissue=Blood;donor_id=CPCG0568;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0568-B1;Tissue=Blood;donor_id=CPCG0568;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0568-B1;Tissue=Blood;donor_id=CPCG0568;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0568-B1;Tissue=Blood;donor_id=CPCG0568;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0568-B1;Tissue=Blood;donor_id=CPCG0568;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0568-B1;Tissue=Blood;donor_id=CPCG0568;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0568-B1;Tissue=Blood;donor_id=CPCG0568;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.9;Sample=CPCG0568-B1;Tissue=Blood;donor_id=CPCG0568;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Sample=CPCG0569-B1;Tissue=Blood;donor_id=CPCG0569;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Sample=CPCG0569-B1;Tissue=Blood;donor_id=CPCG0569;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Sample=CPCG0569-B1;Tissue=Blood;donor_id=CPCG0569;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Sample=CPCG0569-B1;Tissue=Blood;donor_id=CPCG0569;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Sample=CPCG0569-B1;Tissue=Blood;donor_id=CPCG0569;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Sample=CPCG0569-B1;Tissue=Blood;donor_id=CPCG0569;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Sample=CPCG0569-B1;Tissue=Blood;donor_id=CPCG0569;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.5;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Sample=CPCG0569-B1;Tissue=Blood;donor_id=CPCG0569;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000747;PreTreatment PSA=2.1;Tissue=Blood;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000747;PreTreatment PSA=2.1;Tissue=Blood;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000747;PreTreatment PSA=2.1;Tissue=Blood;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000747;PreTreatment PSA=2.1;Tissue=Blood;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000747;PreTreatment PSA=2.1;Tissue=Blood;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000747;PreTreatment PSA=2.1;Tissue=Blood;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000747;PreTreatment PSA=2.1;Tissue=Blood;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000747;PreTreatment PSA=2.1;Tissue=Blood;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10;Tissue=Blood;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10;Tissue=Blood;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10;Tissue=Blood;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10;Tissue=Blood;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10;Tissue=Blood;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10;Tissue=Blood;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10;Tissue=Blood;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10;Tissue=Blood;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.8;Tissue=Blood;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.8;Tissue=Blood;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.8;Tissue=Blood;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.8;Tissue=Blood;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.8;Tissue=Blood;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.8;Tissue=Blood;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.8;Tissue=Blood;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.8;Tissue=Blood;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.8;Tissue=Blood;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.8;Tissue=Blood;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.8;Tissue=Blood;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.8;Tissue=Blood;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.8;Tissue=Blood;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.8;Tissue=Blood;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.8;Tissue=Blood;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.8;Tissue=Blood;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=15.0;Sample=CPCG0574-B1;Tissue=Blood;donor_id=CPCG0574;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=15.0;Sample=CPCG0574-B1;Tissue=Blood;donor_id=CPCG0574;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=15.0;Sample=CPCG0574-B1;Tissue=Blood;donor_id=CPCG0574;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=15.0;Sample=CPCG0574-B1;Tissue=Blood;donor_id=CPCG0574;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=15.0;Sample=CPCG0574-B1;Tissue=Blood;donor_id=CPCG0574;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=15.0;Sample=CPCG0574-B1;Tissue=Blood;donor_id=CPCG0574;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=15.0;Sample=CPCG0574-B1;Tissue=Blood;donor_id=CPCG0574;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.2;gender=male;phenotype=OBI_0000922;PreTreatment PSA=15.0;Sample=CPCG0574-B1;Tissue=Blood;donor_id=CPCG0574;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.49144422;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.4;Tissue=Blood;donor_id=CPCG0575;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.49144422;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.4;Tissue=Blood;donor_id=CPCG0575;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.49144422;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.4;Tissue=Blood;donor_id=CPCG0575;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.49144422;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.4;Tissue=Blood;donor_id=CPCG0575;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.49144422;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.4;Tissue=Blood;donor_id=CPCG0575;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.49144422;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.4;Tissue=Blood;donor_id=CPCG0575;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.49144422;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.4;Tissue=Blood;donor_id=CPCG0575;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.49144422;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.4;Tissue=Blood;donor_id=CPCG0575;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.91512663;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.6;Tissue=Blood;donor_id=CPCG0576;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.91512663;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.6;Tissue=Blood;donor_id=CPCG0576;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.91512663;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.6;Tissue=Blood;donor_id=CPCG0576;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.91512663;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.6;Tissue=Blood;donor_id=CPCG0576;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.91512663;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.6;Tissue=Blood;donor_id=CPCG0576;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.91512663;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.6;Tissue=Blood;donor_id=CPCG0576;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.91512663;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.6;Tissue=Blood;donor_id=CPCG0576;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.91512663;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.6;Tissue=Blood;donor_id=CPCG0576;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.91512663;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.6;Tissue=Blood;donor_id=CPCG0576;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.75770021;gender=male;phenotype=OBI_0000747;PreTreatment PSA=13;Tissue=Blood;donor_id=CPCG0577;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.75770021;gender=male;phenotype=OBI_0000747;PreTreatment PSA=13;Tissue=Blood;donor_id=CPCG0577;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.75770021;gender=male;phenotype=OBI_0000747;PreTreatment PSA=13;Tissue=Blood;donor_id=CPCG0577;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.75770021;gender=male;phenotype=OBI_0000747;PreTreatment PSA=13;Tissue=Blood;donor_id=CPCG0577;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.75770021;gender=male;phenotype=OBI_0000747;PreTreatment PSA=13;Tissue=Blood;donor_id=CPCG0577;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.75770021;gender=male;phenotype=OBI_0000747;PreTreatment PSA=13;Tissue=Blood;donor_id=CPCG0577;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.75770021;gender=male;phenotype=OBI_0000747;PreTreatment PSA=13;Tissue=Blood;donor_id=CPCG0577;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.75770021;gender=male;phenotype=OBI_0000747;PreTreatment PSA=13;Tissue=Blood;donor_id=CPCG0577;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.75770021;gender=male;phenotype=OBI_0000747;PreTreatment PSA=13;Tissue=Blood;donor_id=CPCG0577;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.95345654;gender=male;phenotype=OBI_0000747;PreTreatment PSA=8.5;Tissue=Blood;donor_id=CPCG0578;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.95345654;gender=male;phenotype=OBI_0000747;PreTreatment PSA=8.5;Tissue=Blood;donor_id=CPCG0578;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.95345654;gender=male;phenotype=OBI_0000747;PreTreatment PSA=8.5;Tissue=Blood;donor_id=CPCG0578;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.95345654;gender=male;phenotype=OBI_0000747;PreTreatment PSA=8.5;Tissue=Blood;donor_id=CPCG0578;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.95345654;gender=male;phenotype=OBI_0000747;PreTreatment PSA=8.5;Tissue=Blood;donor_id=CPCG0578;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.95345654;gender=male;phenotype=OBI_0000747;PreTreatment PSA=8.5;Tissue=Blood;donor_id=CPCG0578;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.95345654;gender=male;phenotype=OBI_0000747;PreTreatment PSA=8.5;Tissue=Blood;donor_id=CPCG0578;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.95345654;gender=male;phenotype=OBI_0000747;PreTreatment PSA=8.5;Tissue=Blood;donor_id=CPCG0578;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.95345654;gender=male;phenotype=OBI_0000747;PreTreatment PSA=8.5;Tissue=Blood;donor_id=CPCG0578;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.8;Sample=CPCG0579-B1;Tissue=Blood;donor_id=CPCG0579;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.8;Sample=CPCG0579-B1;Tissue=Blood;donor_id=CPCG0579;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.8;Sample=CPCG0579-B1;Tissue=Blood;donor_id=CPCG0579;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.8;Sample=CPCG0579-B1;Tissue=Blood;donor_id=CPCG0579;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.8;Sample=CPCG0579-B1;Tissue=Blood;donor_id=CPCG0579;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.8;Sample=CPCG0579-B1;Tissue=Blood;donor_id=CPCG0579;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.8;Sample=CPCG0579-B1;Tissue=Blood;donor_id=CPCG0579;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.8;Sample=CPCG0579-B1;Tissue=Blood;donor_id=CPCG0579;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.14989733;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.2;Tissue=Blood;donor_id=CPCG0580;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.14989733;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.2;Tissue=Blood;donor_id=CPCG0580;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.14989733;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.2;Tissue=Blood;donor_id=CPCG0580;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.14989733;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.2;Tissue=Blood;donor_id=CPCG0580;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.14989733;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.2;Tissue=Blood;donor_id=CPCG0580;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.14989733;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.2;Tissue=Blood;donor_id=CPCG0580;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.14989733;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.2;Tissue=Blood;donor_id=CPCG0580;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.14989733;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.2;Tissue=Blood;donor_id=CPCG0580;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.14989733;gender=male;phenotype=OBI_0000747;PreTreatment PSA=3.2;Tissue=Blood;donor_id=CPCG0580;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.93360712;gender=male;phenotype=OBI_0000747;PreTreatment PSA=12.5;Tissue=Blood;donor_id=CPCG0581;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.93360712;gender=male;phenotype=OBI_0000747;PreTreatment PSA=12.5;Tissue=Blood;donor_id=CPCG0581;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.93360712;gender=male;phenotype=OBI_0000747;PreTreatment PSA=12.5;Tissue=Blood;donor_id=CPCG0581;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.93360712;gender=male;phenotype=OBI_0000747;PreTreatment PSA=12.5;Tissue=Blood;donor_id=CPCG0581;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.93360712;gender=male;phenotype=OBI_0000747;PreTreatment PSA=12.5;Tissue=Blood;donor_id=CPCG0581;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.93360712;gender=male;phenotype=OBI_0000747;PreTreatment PSA=12.5;Tissue=Blood;donor_id=CPCG0581;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.93360712;gender=male;phenotype=OBI_0000747;PreTreatment PSA=12.5;Tissue=Blood;donor_id=CPCG0581;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.93360712;gender=male;phenotype=OBI_0000747;PreTreatment PSA=12.5;Tissue=Blood;donor_id=CPCG0581;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.68925394;gender=male;phenotype=OBI_0000747;PreTreatment PSA=13.2;Tissue=Blood;donor_id=CPCG0582;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.68925394;gender=male;phenotype=OBI_0000747;PreTreatment PSA=13.2;Tissue=Blood;donor_id=CPCG0582;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.68925394;gender=male;phenotype=OBI_0000747;PreTreatment PSA=13.2;Tissue=Blood;donor_id=CPCG0582;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.68925394;gender=male;phenotype=OBI_0000747;PreTreatment PSA=13.2;Tissue=Blood;donor_id=CPCG0582;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.68925394;gender=male;phenotype=OBI_0000747;PreTreatment PSA=13.2;Tissue=Blood;donor_id=CPCG0582;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.68925394;gender=male;phenotype=OBI_0000747;PreTreatment PSA=13.2;Tissue=Blood;donor_id=CPCG0582;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.68925394;gender=male;phenotype=OBI_0000747;PreTreatment PSA=13.2;Tissue=Blood;donor_id=CPCG0582;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.68925394;gender=male;phenotype=OBI_0000747;PreTreatment PSA=13.2;Tissue=Blood;donor_id=CPCG0582;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.03080082;gender=male;phenotype=OBI_0000747;PreTreatment PSA=5.6;Tissue=Blood;donor_id=CPCG0584;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.03080082;gender=male;phenotype=OBI_0000747;PreTreatment PSA=5.6;Tissue=Blood;donor_id=CPCG0584;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.03080082;gender=male;phenotype=OBI_0000747;PreTreatment PSA=5.6;Tissue=Blood;donor_id=CPCG0584;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.03080082;gender=male;phenotype=OBI_0000747;PreTreatment PSA=5.6;Tissue=Blood;donor_id=CPCG0584;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.03080082;gender=male;phenotype=OBI_0000747;PreTreatment PSA=5.6;Tissue=Blood;donor_id=CPCG0584;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.03080082;gender=male;phenotype=OBI_0000747;PreTreatment PSA=5.6;Tissue=Blood;donor_id=CPCG0584;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.03080082;gender=male;phenotype=OBI_0000747;PreTreatment PSA=5.6;Tissue=Blood;donor_id=CPCG0584;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.03080082;gender=male;phenotype=OBI_0000747;PreTreatment PSA=5.6;Tissue=Blood;donor_id=CPCG0584;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.69130732;gender=male;phenotype=OBI_0000747;PreTreatment PSA=9.4;Tissue=Blood;donor_id=CPCG0587;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.69130732;gender=male;phenotype=OBI_0000747;PreTreatment PSA=9.4;Tissue=Blood;donor_id=CPCG0587;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.69130732;gender=male;phenotype=OBI_0000747;PreTreatment PSA=9.4;Tissue=Blood;donor_id=CPCG0587;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.69130732;gender=male;phenotype=OBI_0000747;PreTreatment PSA=9.4;Tissue=Blood;donor_id=CPCG0587;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.69130732;gender=male;phenotype=OBI_0000747;PreTreatment PSA=9.4;Tissue=Blood;donor_id=CPCG0587;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.69130732;gender=male;phenotype=OBI_0000747;PreTreatment PSA=9.4;Tissue=Blood;donor_id=CPCG0587;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.69130732;gender=male;phenotype=OBI_0000747;PreTreatment PSA=9.4;Tissue=Blood;donor_id=CPCG0587;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.69130732;gender=male;phenotype=OBI_0000747;PreTreatment PSA=9.4;Tissue=Blood;donor_id=CPCG0587;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.05407255;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.3;Tissue=Blood;donor_id=CPCG0588;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.05407255;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.3;Tissue=Blood;donor_id=CPCG0588;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.05407255;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.3;Tissue=Blood;donor_id=CPCG0588;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.05407255;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.3;Tissue=Blood;donor_id=CPCG0588;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.05407255;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.3;Tissue=Blood;donor_id=CPCG0588;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.05407255;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.3;Tissue=Blood;donor_id=CPCG0588;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.05407255;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.3;Tissue=Blood;donor_id=CPCG0588;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.05407255;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.3;Tissue=Blood;donor_id=CPCG0588;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=12.2;Sample=CPCG0589-B1;Tissue=Blood;donor_id=CPCG0589;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=12.2;Sample=CPCG0589-B1;Tissue=Blood;donor_id=CPCG0589;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=12.2;Sample=CPCG0589-B1;Tissue=Blood;donor_id=CPCG0589;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=12.2;Sample=CPCG0589-B1;Tissue=Blood;donor_id=CPCG0589;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=12.2;Sample=CPCG0589-B1;Tissue=Blood;donor_id=CPCG0589;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=12.2;Sample=CPCG0589-B1;Tissue=Blood;donor_id=CPCG0589;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=12.2;Sample=CPCG0589-B1;Tissue=Blood;donor_id=CPCG0589;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.6;gender=male;phenotype=OBI_0000922;PreTreatment PSA=12.2;Sample=CPCG0589-B1;Tissue=Blood;donor_id=CPCG0589;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.14373717;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.9;Tissue=Blood;donor_id=CPCG0590;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.14373717;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.9;Tissue=Blood;donor_id=CPCG0590;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.14373717;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.9;Tissue=Blood;donor_id=CPCG0590;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.14373717;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.9;Tissue=Blood;donor_id=CPCG0590;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.14373717;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.9;Tissue=Blood;donor_id=CPCG0590;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.14373717;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.9;Tissue=Blood;donor_id=CPCG0590;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.14373717;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.9;Tissue=Blood;donor_id=CPCG0590;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.14373717;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.9;Tissue=Blood;donor_id=CPCG0590;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.59685147;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.1;Tissue=Blood;donor_id=CPCG0591;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.59685147;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.1;Tissue=Blood;donor_id=CPCG0591;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.59685147;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.1;Tissue=Blood;donor_id=CPCG0591;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.59685147;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.1;Tissue=Blood;donor_id=CPCG0591;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.59685147;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.1;Tissue=Blood;donor_id=CPCG0591;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.59685147;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.1;Tissue=Blood;donor_id=CPCG0591;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.59685147;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.1;Tissue=Blood;donor_id=CPCG0591;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.6;Sample=CPCG0592-B1;Tissue=Blood;donor_id=CPCG0592;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.6;Sample=CPCG0592-B1;Tissue=Blood;donor_id=CPCG0592;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.6;Sample=CPCG0592-B1;Tissue=Blood;donor_id=CPCG0592;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.6;Sample=CPCG0592-B1;Tissue=Blood;donor_id=CPCG0592;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.6;Sample=CPCG0592-B1;Tissue=Blood;donor_id=CPCG0592;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.6;Sample=CPCG0592-B1;Tissue=Blood;donor_id=CPCG0592;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.6;Sample=CPCG0592-B1;Tissue=Blood;donor_id=CPCG0592;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.4;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.6;Sample=CPCG0592-B1;Tissue=Blood;donor_id=CPCG0592;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.99383984;gender=male;phenotype=OBI_0000747;PreTreatment PSA=15;Tissue=Blood;donor_id=CPCG0593;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.99383984;gender=male;phenotype=OBI_0000747;PreTreatment PSA=15;Tissue=Blood;donor_id=CPCG0593;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.99383984;gender=male;phenotype=OBI_0000747;PreTreatment PSA=15;Tissue=Blood;donor_id=CPCG0593;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.99383984;gender=male;phenotype=OBI_0000747;PreTreatment PSA=15;Tissue=Blood;donor_id=CPCG0593;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.99383984;gender=male;phenotype=OBI_0000747;PreTreatment PSA=15;Tissue=Blood;donor_id=CPCG0593;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.99383984;gender=male;phenotype=OBI_0000747;PreTreatment PSA=15;Tissue=Blood;donor_id=CPCG0593;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.99383984;gender=male;phenotype=OBI_0000747;PreTreatment PSA=15;Tissue=Blood;donor_id=CPCG0593;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.99383984;gender=male;phenotype=OBI_0000747;PreTreatment PSA=15;Tissue=Blood;donor_id=CPCG0593;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.6;Sample=CPCG0594-B1;Tissue=Blood;donor_id=CPCG0594;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.6;Sample=CPCG0594-B1;Tissue=Blood;donor_id=CPCG0594;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.6;Sample=CPCG0594-B1;Tissue=Blood;donor_id=CPCG0594;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.6;Sample=CPCG0594-B1;Tissue=Blood;donor_id=CPCG0594;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.6;Sample=CPCG0594-B1;Tissue=Blood;donor_id=CPCG0594;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.6;Sample=CPCG0594-B1;Tissue=Blood;donor_id=CPCG0594;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.6;Sample=CPCG0594-B1;Tissue=Blood;donor_id=CPCG0594;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.1;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.6;Sample=CPCG0594-B1;Tissue=Blood;donor_id=CPCG0594;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.68651608;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0595;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.68651608;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0595;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.68651608;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0595;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.68651608;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0595;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.68651608;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0595;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.68651608;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0595;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.68651608;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0595;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.68651608;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0595;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.67008898;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.4;Tissue=Blood;donor_id=CPCG0596;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.67008898;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.4;Tissue=Blood;donor_id=CPCG0596;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.67008898;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.4;Tissue=Blood;donor_id=CPCG0596;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.67008898;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.4;Tissue=Blood;donor_id=CPCG0596;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.67008898;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.4;Tissue=Blood;donor_id=CPCG0596;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.67008898;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.4;Tissue=Blood;donor_id=CPCG0596;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.67008898;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.4;Tissue=Blood;donor_id=CPCG0596;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.67008898;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.4;Tissue=Blood;donor_id=CPCG0596;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.66872005;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.4;Tissue=Blood;donor_id=CPCG0597;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.66872005;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.4;Tissue=Blood;donor_id=CPCG0597;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.66872005;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.4;Tissue=Blood;donor_id=CPCG0597;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.66872005;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.4;Tissue=Blood;donor_id=CPCG0597;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.66872005;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.4;Tissue=Blood;donor_id=CPCG0597;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.66872005;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.4;Tissue=Blood;donor_id=CPCG0597;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.66872005;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.4;Tissue=Blood;donor_id=CPCG0597;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.66872005;gender=male;phenotype=OBI_0000747;PreTreatment PSA=7.4;Tissue=Blood;donor_id=CPCG0597;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.79534565;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0598;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.79534565;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0598;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.79534565;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0598;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.79534565;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0598;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.79534565;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0598;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.79534565;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0598;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.79534565;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0598;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.79534565;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0598;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.26283368;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10.5;Tissue=Blood;donor_id=CPCG0599;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.26283368;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10.5;Tissue=Blood;donor_id=CPCG0599;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.26283368;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10.5;Tissue=Blood;donor_id=CPCG0599;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.26283368;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10.5;Tissue=Blood;donor_id=CPCG0599;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.26283368;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10.5;Tissue=Blood;donor_id=CPCG0599;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.26283368;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10.5;Tissue=Blood;donor_id=CPCG0599;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.26283368;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10.5;Tissue=Blood;donor_id=CPCG0599;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.26283368;gender=male;phenotype=OBI_0000747;PreTreatment PSA=10.5;Tissue=Blood;donor_id=CPCG0599;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.95893224;gender=male;phenotype=OBI_0000747;PreTreatment PSA=9.4;Tissue=Blood;donor_id=CPCG0600;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.95893224;gender=male;phenotype=OBI_0000747;PreTreatment PSA=9.4;Tissue=Blood;donor_id=CPCG0600;ENA-CHECKLIST=ERC000026;
Age at Treatment=57.51676934;gender=male;phenotype=OBI_0000747;PreTreatment PSA=8.9;Tissue=Blood;donor_id=CPCG0601;ENA-CHECKLIST=ERC000026;
Age at Treatment=57.51676934;gender=male;phenotype=OBI_0000747;PreTreatment PSA=8.9;Tissue=Blood;donor_id=CPCG0601;ENA-CHECKLIST=ERC000026;
Age at Treatment=57.51676934;gender=male;phenotype=OBI_0000747;PreTreatment PSA=8.9;Tissue=Blood;donor_id=CPCG0601;ENA-CHECKLIST=ERC000026;
Age at Treatment=57.51676934;gender=male;phenotype=OBI_0000747;PreTreatment PSA=8.9;Tissue=Blood;donor_id=CPCG0601;ENA-CHECKLIST=ERC000026;
Age at Treatment=57.51676934;gender=male;phenotype=OBI_0000747;PreTreatment PSA=8.9;Tissue=Blood;donor_id=CPCG0601;ENA-CHECKLIST=ERC000026;
Age at Treatment=57.51676934;gender=male;phenotype=OBI_0000747;PreTreatment PSA=8.9;Tissue=Blood;donor_id=CPCG0601;ENA-CHECKLIST=ERC000026;
Age at Treatment=57.51676934;gender=male;phenotype=OBI_0000747;PreTreatment PSA=8.9;Tissue=Blood;donor_id=CPCG0601;ENA-CHECKLIST=ERC000026;
Age at Treatment=57.51676934;gender=male;phenotype=OBI_0000747;PreTreatment PSA=8.9;Tissue=Blood;donor_id=CPCG0601;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.3;Sample=CPCG0602-B1;Tissue=Blood;donor_id=CPCG0602;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.3;Sample=CPCG0602-B1;Tissue=Blood;donor_id=CPCG0602;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.3;Sample=CPCG0602-B1;Tissue=Blood;donor_id=CPCG0602;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.3;Sample=CPCG0602-B1;Tissue=Blood;donor_id=CPCG0602;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.3;Sample=CPCG0602-B1;Tissue=Blood;donor_id=CPCG0602;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.3;Sample=CPCG0602-B1;Tissue=Blood;donor_id=CPCG0602;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.3;Sample=CPCG0602-B1;Tissue=Blood;donor_id=CPCG0602;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.0;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.3;Sample=CPCG0602-B1;Tissue=Blood;donor_id=CPCG0602;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.4;gender=male;phenotype=OBI_0000922;Sample=CPCG0603-B1;Tissue=Blood;donor_id=CPCG0603;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.4;gender=male;phenotype=OBI_0000922;Sample=CPCG0603-B1;Tissue=Blood;donor_id=CPCG0603;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.4;gender=male;phenotype=OBI_0000922;Sample=CPCG0603-B1;Tissue=Blood;donor_id=CPCG0603;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.4;gender=male;phenotype=OBI_0000922;Sample=CPCG0603-B1;Tissue=Blood;donor_id=CPCG0603;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.4;gender=male;phenotype=OBI_0000922;Sample=CPCG0603-B1;Tissue=Blood;donor_id=CPCG0603;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.4;gender=male;phenotype=OBI_0000922;Sample=CPCG0603-B1;Tissue=Blood;donor_id=CPCG0603;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.4;gender=male;phenotype=OBI_0000922;Sample=CPCG0603-B1;Tissue=Blood;donor_id=CPCG0603;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.4;gender=male;phenotype=OBI_0000922;Sample=CPCG0603-B1;Tissue=Blood;donor_id=CPCG0603;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.29021218;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.5;Tissue=Blood;donor_id=CPCG0604;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.29021218;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.5;Tissue=Blood;donor_id=CPCG0604;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.29021218;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.5;Tissue=Blood;donor_id=CPCG0604;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.29021218;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.5;Tissue=Blood;donor_id=CPCG0604;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.29021218;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.5;Tissue=Blood;donor_id=CPCG0604;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.29021218;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.5;Tissue=Blood;donor_id=CPCG0604;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.29021218;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.5;Tissue=Blood;donor_id=CPCG0604;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.29021218;gender=male;phenotype=OBI_0000747;PreTreatment PSA=6.5;Tissue=Blood;donor_id=CPCG0604;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.70978782;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0605;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.70978782;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0605;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.70978782;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0605;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.70978782;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0605;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.70978782;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0605;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.70978782;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0605;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.70978782;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0605;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.70978782;gender=male;phenotype=OBI_0000747;PreTreatment PSA=4.7;Tissue=Blood;donor_id=CPCG0605;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.38398357;gender=male;phenotype=OBI_0000747;PreTreatment PSA=18.7;Tissue=Blood;donor_id=CPCG0606;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.38398357;gender=male;phenotype=OBI_0000747;PreTreatment PSA=18.7;Tissue=Blood;donor_id=CPCG0606;ENA-CHECKLIST=ERC000026;
Age at Treatment=74.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.7;Sample=CPCG0607-B1;Tissue=Blood;donor_id=CPCG0607;ENA-CHECKLIST=ERC000026;
Age at Treatment=74.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.7;Sample=CPCG0607-B1;Tissue=Blood;donor_id=CPCG0607;ENA-CHECKLIST=ERC000026;
Age at Treatment=74.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.7;Sample=CPCG0607-B1;Tissue=Blood;donor_id=CPCG0607;ENA-CHECKLIST=ERC000026;
Age at Treatment=74.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.7;Sample=CPCG0607-B1;Tissue=Blood;donor_id=CPCG0607;ENA-CHECKLIST=ERC000026;
Age at Treatment=74.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.7;Sample=CPCG0607-B1;Tissue=Blood;donor_id=CPCG0607;ENA-CHECKLIST=ERC000026;
Age at Treatment=74.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.7;Sample=CPCG0607-B1;Tissue=Blood;donor_id=CPCG0607;ENA-CHECKLIST=ERC000026;
Age at Treatment=74.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.7;Sample=CPCG0607-B1;Tissue=Blood;donor_id=CPCG0607;ENA-CHECKLIST=ERC000026;
Age at Treatment=74.3;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.7;Sample=CPCG0607-B1;Tissue=Blood;donor_id=CPCG0607;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.50992471;gender=male;phenotype=OBI_0000922;PreTreatment PSA=1.97;Tissue=Prostate Tumour;donor_id=CPCG0192;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.50992471;gender=male;phenotype=OBI_0000922;PreTreatment PSA=1.97;Tissue=Prostate Tumour;donor_id=CPCG0192;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.50992471;gender=male;phenotype=OBI_0000922;PreTreatment PSA=1.97;Tissue=Prostate Tumour;donor_id=CPCG0192;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.50992471;gender=male;phenotype=OBI_0000922;PreTreatment PSA=1.97;Tissue=Prostate Tumour;donor_id=CPCG0192;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.50992471;gender=male;phenotype=OBI_0000922;PreTreatment PSA=1.97;Tissue=Prostate Tumour;donor_id=CPCG0192;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.50992471;gender=male;phenotype=OBI_0000922;PreTreatment PSA=1.97;Tissue=Prostate Tumour;donor_id=CPCG0192;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.50992471;gender=male;phenotype=OBI_0000922;PreTreatment PSA=1.97;Tissue=Prostate Tumour;donor_id=CPCG0192;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.50992471;gender=male;phenotype=OBI_0000922;PreTreatment PSA=1.97;Tissue=Prostate Tumour;donor_id=CPCG0192;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.50992471;gender=male;phenotype=OBI_0000922;PreTreatment PSA=1.97;Tissue=Prostate Tumour;donor_id=CPCG0192;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.50992471;gender=male;phenotype=OBI_0000922;PreTreatment PSA=1.97;Tissue=Prostate Tumour;donor_id=CPCG0192;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.50992471;gender=male;phenotype=OBI_0000922;PreTreatment PSA=1.97;Tissue=Prostate Tumour;donor_id=CPCG0192;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.50992471;gender=male;phenotype=OBI_0000922;PreTreatment PSA=1.97;Tissue=Prostate Tumour;donor_id=CPCG0192;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.50992471;gender=male;phenotype=OBI_0000922;PreTreatment PSA=1.97;Tissue=Prostate Tumour;donor_id=CPCG0192;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.50992471;gender=male;phenotype=OBI_0000922;PreTreatment PSA=1.97;Tissue=Prostate Tumour;donor_id=CPCG0192;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.50992471;gender=male;phenotype=OBI_0000922;PreTreatment PSA=1.97;Tissue=Prostate Tumour;donor_id=CPCG0192;ENA-CHECKLIST=ERC000026;
Age at Treatment=51.50992471;gender=male;phenotype=OBI_0000922;PreTreatment PSA=1.97;Tissue=Prostate Tumour;donor_id=CPCG0192;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.7;gender=male;Gleason Score=3+4;phenotype=OBI_0000922;PreTreatment PSA=5.2;Sample=CPCG0198-F1;Tissue=Prostate Tumour;donor_id=CPCG0198;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.7;gender=male;Gleason Score=3+4;phenotype=OBI_0000922;PreTreatment PSA=5.2;Sample=CPCG0198-F1;Tissue=Prostate Tumour;donor_id=CPCG0198;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.7;gender=male;Gleason Score=3+4;phenotype=OBI_0000922;PreTreatment PSA=5.2;Sample=CPCG0198-F1;Tissue=Prostate Tumour;donor_id=CPCG0198;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.7;gender=male;Gleason Score=3+4;phenotype=OBI_0000922;PreTreatment PSA=5.2;Sample=CPCG0198-F1;Tissue=Prostate Tumour;donor_id=CPCG0198;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.7;gender=male;Gleason Score=3+4;phenotype=OBI_0000922;PreTreatment PSA=5.2;Sample=CPCG0198-F1;Tissue=Prostate Tumour;donor_id=CPCG0198;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.7;gender=male;Gleason Score=3+4;phenotype=OBI_0000922;PreTreatment PSA=5.2;Sample=CPCG0198-F1;Tissue=Prostate Tumour;donor_id=CPCG0198;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.15947981;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.84;Tissue=Prostate Tumour;donor_id=CPCG0547;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.15947981;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.84;Tissue=Prostate Tumour;donor_id=CPCG0547;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.15947981;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.84;Tissue=Prostate Tumour;donor_id=CPCG0547;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.15947981;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.84;Tissue=Prostate Tumour;donor_id=CPCG0547;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.15947981;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.84;Tissue=Prostate Tumour;donor_id=CPCG0547;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.15947981;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.84;Tissue=Prostate Tumour;donor_id=CPCG0547;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.15947981;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.84;Tissue=Prostate Tumour;donor_id=CPCG0547;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.15947981;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.84;Tissue=Prostate Tumour;donor_id=CPCG0547;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.15947981;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.84;Tissue=Prostate Tumour;donor_id=CPCG0547;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.15947981;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.84;Tissue=Prostate Tumour;donor_id=CPCG0547;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.15947981;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.84;Tissue=Prostate Tumour;donor_id=CPCG0547;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.15947981;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.84;Tissue=Prostate Tumour;donor_id=CPCG0547;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.15947981;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.84;Tissue=Prostate Tumour;donor_id=CPCG0547;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.15947981;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.84;Tissue=Prostate Tumour;donor_id=CPCG0547;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.15947981;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.84;Tissue=Prostate Tumour;donor_id=CPCG0547;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.15947981;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.84;Tissue=Prostate Tumour;donor_id=CPCG0547;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.66187543;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.59;Tissue=Prostate Tumour;donor_id=CPCG0550;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.66187543;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.59;Tissue=Prostate Tumour;donor_id=CPCG0550;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.66187543;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.59;Tissue=Prostate Tumour;donor_id=CPCG0550;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.66187543;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.59;Tissue=Prostate Tumour;donor_id=CPCG0550;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.66187543;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.59;Tissue=Prostate Tumour;donor_id=CPCG0550;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.66187543;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.59;Tissue=Prostate Tumour;donor_id=CPCG0550;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.66187543;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.59;Tissue=Prostate Tumour;donor_id=CPCG0550;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.66187543;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.59;Tissue=Prostate Tumour;donor_id=CPCG0550;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.66187543;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.59;Tissue=Prostate Tumour;donor_id=CPCG0550;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.66187543;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.59;Tissue=Prostate Tumour;donor_id=CPCG0550;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.66187543;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.59;Tissue=Prostate Tumour;donor_id=CPCG0550;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.66187543;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.59;Tissue=Prostate Tumour;donor_id=CPCG0550;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.66187543;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.59;Tissue=Prostate Tumour;donor_id=CPCG0550;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.66187543;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.59;Tissue=Prostate Tumour;donor_id=CPCG0550;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.66187543;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.59;Tissue=Prostate Tumour;donor_id=CPCG0550;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.66187543;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.59;Tissue=Prostate Tumour;donor_id=CPCG0550;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.13483915;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Tissue=Prostate Tumour;donor_id=CPCG0551;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.13483915;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Tissue=Prostate Tumour;donor_id=CPCG0551;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.13483915;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Tissue=Prostate Tumour;donor_id=CPCG0551;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.13483915;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Tissue=Prostate Tumour;donor_id=CPCG0551;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.13483915;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Tissue=Prostate Tumour;donor_id=CPCG0551;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.13483915;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Tissue=Prostate Tumour;donor_id=CPCG0551;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.13483915;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Tissue=Prostate Tumour;donor_id=CPCG0551;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.13483915;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Tissue=Prostate Tumour;donor_id=CPCG0551;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.13483915;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Tissue=Prostate Tumour;donor_id=CPCG0551;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.13483915;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Tissue=Prostate Tumour;donor_id=CPCG0551;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.13483915;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Tissue=Prostate Tumour;donor_id=CPCG0551;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.13483915;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Tissue=Prostate Tumour;donor_id=CPCG0551;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.13483915;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Tissue=Prostate Tumour;donor_id=CPCG0551;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.13483915;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Tissue=Prostate Tumour;donor_id=CPCG0551;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.13483915;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Tissue=Prostate Tumour;donor_id=CPCG0551;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.13483915;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.2;Tissue=Prostate Tumour;donor_id=CPCG0551;ENA-CHECKLIST=ERC000026;
donor_id=CPCG0556;gender=male;Germline BRCA Status=MT;IDC-P Status=Negative;phenotype=Prostate Cancer;Sample=CPCG0556-F1;Tissue Source=UHN-Toronto,Canada;Tissue Type=Gross Tumour;ENA-CHECKLIST=ERC000026;
Age at Treatment=45.52498289;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.74;Tissue=Prostate Tumour;donor_id=CPCG0557;ENA-CHECKLIST=ERC000026;
Age at Treatment=45.52498289;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.74;Tissue=Prostate Tumour;donor_id=CPCG0557;ENA-CHECKLIST=ERC000026;
Age at Treatment=45.52498289;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.74;Tissue=Prostate Tumour;donor_id=CPCG0557;ENA-CHECKLIST=ERC000026;
Age at Treatment=45.52498289;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.74;Tissue=Prostate Tumour;donor_id=CPCG0557;ENA-CHECKLIST=ERC000026;
Age at Treatment=45.52498289;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.74;Tissue=Prostate Tumour;donor_id=CPCG0557;ENA-CHECKLIST=ERC000026;
Age at Treatment=45.52498289;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.74;Tissue=Prostate Tumour;donor_id=CPCG0557;ENA-CHECKLIST=ERC000026;
Age at Treatment=45.52498289;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.74;Tissue=Prostate Tumour;donor_id=CPCG0557;ENA-CHECKLIST=ERC000026;
Age at Treatment=45.52498289;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.74;Tissue=Prostate Tumour;donor_id=CPCG0557;ENA-CHECKLIST=ERC000026;
Age at Treatment=45.52498289;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.74;Tissue=Prostate Tumour;donor_id=CPCG0557;ENA-CHECKLIST=ERC000026;
Age at Treatment=45.52498289;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.74;Tissue=Prostate Tumour;donor_id=CPCG0557;ENA-CHECKLIST=ERC000026;
Age at Treatment=45.52498289;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.74;Tissue=Prostate Tumour;donor_id=CPCG0557;ENA-CHECKLIST=ERC000026;
Age at Treatment=45.52498289;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.74;Tissue=Prostate Tumour;donor_id=CPCG0557;ENA-CHECKLIST=ERC000026;
Age at Treatment=45.52498289;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.74;Tissue=Prostate Tumour;donor_id=CPCG0557;ENA-CHECKLIST=ERC000026;
Age at Treatment=45.52498289;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.74;Tissue=Prostate Tumour;donor_id=CPCG0557;ENA-CHECKLIST=ERC000026;
Age at Treatment=45.52498289;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.74;Tissue=Prostate Tumour;donor_id=CPCG0557;ENA-CHECKLIST=ERC000026;
Age at Treatment=45.52498289;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.74;Tissue=Prostate Tumour;donor_id=CPCG0557;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2881588;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.2;Tissue=Prostate Tumour;donor_id=CPCG0559;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2881588;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.2;Tissue=Prostate Tumour;donor_id=CPCG0559;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2881588;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.2;Tissue=Prostate Tumour;donor_id=CPCG0559;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2881588;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.2;Tissue=Prostate Tumour;donor_id=CPCG0559;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2881588;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.2;Tissue=Prostate Tumour;donor_id=CPCG0559;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2881588;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.2;Tissue=Prostate Tumour;donor_id=CPCG0559;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2881588;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.2;Tissue=Prostate Tumour;donor_id=CPCG0559;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2881588;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.2;Tissue=Prostate Tumour;donor_id=CPCG0559;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2881588;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.2;Tissue=Prostate Tumour;donor_id=CPCG0559;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2881588;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.2;Tissue=Prostate Tumour;donor_id=CPCG0559;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2881588;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.2;Tissue=Prostate Tumour;donor_id=CPCG0559;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2881588;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.2;Tissue=Prostate Tumour;donor_id=CPCG0559;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2881588;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.2;Tissue=Prostate Tumour;donor_id=CPCG0559;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2881588;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.2;Tissue=Prostate Tumour;donor_id=CPCG0559;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2881588;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.2;Tissue=Prostate Tumour;donor_id=CPCG0559;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.2881588;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.2;Tissue=Prostate Tumour;donor_id=CPCG0559;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.81382615;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Tissue=Prostate Tumour;donor_id=CPCG0560;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.81382615;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Tissue=Prostate Tumour;donor_id=CPCG0560;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.81382615;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Tissue=Prostate Tumour;donor_id=CPCG0560;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.81382615;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Tissue=Prostate Tumour;donor_id=CPCG0560;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.81382615;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Tissue=Prostate Tumour;donor_id=CPCG0560;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.81382615;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Tissue=Prostate Tumour;donor_id=CPCG0560;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.81382615;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Tissue=Prostate Tumour;donor_id=CPCG0560;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.81382615;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Tissue=Prostate Tumour;donor_id=CPCG0560;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.81382615;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Tissue=Prostate Tumour;donor_id=CPCG0560;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.81382615;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Tissue=Prostate Tumour;donor_id=CPCG0560;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.81382615;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Tissue=Prostate Tumour;donor_id=CPCG0560;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.81382615;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Tissue=Prostate Tumour;donor_id=CPCG0560;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.81382615;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Tissue=Prostate Tumour;donor_id=CPCG0560;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.81382615;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Tissue=Prostate Tumour;donor_id=CPCG0560;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.81382615;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Tissue=Prostate Tumour;donor_id=CPCG0560;ENA-CHECKLIST=ERC000026;
Age at Treatment=71.81382615;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.6;Tissue=Prostate Tumour;donor_id=CPCG0560;ENA-CHECKLIST=ERC000026;
Age at Treatment=56.24640657;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Tissue=Prostate Tumour;donor_id=CPCG0561;ENA-CHECKLIST=ERC000026;
Age at Treatment=56.24640657;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Tissue=Prostate Tumour;donor_id=CPCG0561;ENA-CHECKLIST=ERC000026;
Age at Treatment=56.24640657;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Tissue=Prostate Tumour;donor_id=CPCG0561;ENA-CHECKLIST=ERC000026;
Age at Treatment=56.24640657;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Tissue=Prostate Tumour;donor_id=CPCG0561;ENA-CHECKLIST=ERC000026;
Age at Treatment=56.24640657;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Tissue=Prostate Tumour;donor_id=CPCG0561;ENA-CHECKLIST=ERC000026;
Age at Treatment=56.24640657;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Tissue=Prostate Tumour;donor_id=CPCG0561;ENA-CHECKLIST=ERC000026;
Age at Treatment=56.24640657;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Tissue=Prostate Tumour;donor_id=CPCG0561;ENA-CHECKLIST=ERC000026;
Age at Treatment=56.24640657;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Tissue=Prostate Tumour;donor_id=CPCG0561;ENA-CHECKLIST=ERC000026;
Age at Treatment=56.24640657;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Tissue=Prostate Tumour;donor_id=CPCG0561;ENA-CHECKLIST=ERC000026;
Age at Treatment=56.24640657;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Tissue=Prostate Tumour;donor_id=CPCG0561;ENA-CHECKLIST=ERC000026;
Age at Treatment=56.24640657;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Tissue=Prostate Tumour;donor_id=CPCG0561;ENA-CHECKLIST=ERC000026;
Age at Treatment=56.24640657;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Tissue=Prostate Tumour;donor_id=CPCG0561;ENA-CHECKLIST=ERC000026;
Age at Treatment=56.24640657;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Tissue=Prostate Tumour;donor_id=CPCG0561;ENA-CHECKLIST=ERC000026;
Age at Treatment=56.24640657;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Tissue=Prostate Tumour;donor_id=CPCG0561;ENA-CHECKLIST=ERC000026;
Age at Treatment=56.24640657;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Tissue=Prostate Tumour;donor_id=CPCG0561;ENA-CHECKLIST=ERC000026;
Age at Treatment=56.24640657;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.3;Tissue=Prostate Tumour;donor_id=CPCG0561;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.64750171;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.7;Tissue=Prostate Tumour;donor_id=CPCG0562;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.64750171;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.7;Tissue=Prostate Tumour;donor_id=CPCG0562;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.64750171;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.7;Tissue=Prostate Tumour;donor_id=CPCG0562;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.64750171;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.7;Tissue=Prostate Tumour;donor_id=CPCG0562;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.64750171;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.7;Tissue=Prostate Tumour;donor_id=CPCG0562;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.64750171;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.7;Tissue=Prostate Tumour;donor_id=CPCG0562;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.64750171;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.7;Tissue=Prostate Tumour;donor_id=CPCG0562;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.64750171;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.7;Tissue=Prostate Tumour;donor_id=CPCG0562;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.64750171;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.7;Tissue=Prostate Tumour;donor_id=CPCG0562;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.64750171;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.7;Tissue=Prostate Tumour;donor_id=CPCG0562;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.64750171;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.7;Tissue=Prostate Tumour;donor_id=CPCG0562;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.64750171;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.7;Tissue=Prostate Tumour;donor_id=CPCG0562;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.64750171;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.7;Tissue=Prostate Tumour;donor_id=CPCG0562;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.64750171;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.7;Tissue=Prostate Tumour;donor_id=CPCG0562;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.64750171;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.7;Tissue=Prostate Tumour;donor_id=CPCG0562;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.64750171;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.7;Tissue=Prostate Tumour;donor_id=CPCG0562;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.6;Tissue=Prostate Tumour;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.6;Tissue=Prostate Tumour;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.6;Tissue=Prostate Tumour;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.6;Tissue=Prostate Tumour;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.6;Tissue=Prostate Tumour;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.6;Tissue=Prostate Tumour;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.6;Tissue=Prostate Tumour;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.6;Tissue=Prostate Tumour;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.6;Tissue=Prostate Tumour;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.6;Tissue=Prostate Tumour;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.6;Tissue=Prostate Tumour;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.6;Tissue=Prostate Tumour;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.6;Tissue=Prostate Tumour;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.6;Tissue=Prostate Tumour;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.6;Tissue=Prostate Tumour;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=72.00273785;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.6;Tissue=Prostate Tumour;donor_id=CPCG0565;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.6;Tissue=Prostate Tumour;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.6;Tissue=Prostate Tumour;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.6;Tissue=Prostate Tumour;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.6;Tissue=Prostate Tumour;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.6;Tissue=Prostate Tumour;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.6;Tissue=Prostate Tumour;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.6;Tissue=Prostate Tumour;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.6;Tissue=Prostate Tumour;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.6;Tissue=Prostate Tumour;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.6;Tissue=Prostate Tumour;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.6;Tissue=Prostate Tumour;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.6;Tissue=Prostate Tumour;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.6;Tissue=Prostate Tumour;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.6;Tissue=Prostate Tumour;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.6;Tissue=Prostate Tumour;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.91238877;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.6;Tissue=Prostate Tumour;donor_id=CPCG0566;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.6;Tissue=Prostate Tumour;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.6;Tissue=Prostate Tumour;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.6;Tissue=Prostate Tumour;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.6;Tissue=Prostate Tumour;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.6;Tissue=Prostate Tumour;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.6;Tissue=Prostate Tumour;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.6;Tissue=Prostate Tumour;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.6;Tissue=Prostate Tumour;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.6;Tissue=Prostate Tumour;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.6;Tissue=Prostate Tumour;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.6;Tissue=Prostate Tumour;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.6;Tissue=Prostate Tumour;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.6;Tissue=Prostate Tumour;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.6;Tissue=Prostate Tumour;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.6;Tissue=Prostate Tumour;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=54.9650924;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.6;Tissue=Prostate Tumour;donor_id=CPCG0567;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.1;Tissue=Prostate Tumour;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.1;Tissue=Prostate Tumour;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.1;Tissue=Prostate Tumour;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.1;Tissue=Prostate Tumour;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.1;Tissue=Prostate Tumour;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.1;Tissue=Prostate Tumour;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.1;Tissue=Prostate Tumour;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.1;Tissue=Prostate Tumour;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.1;Tissue=Prostate Tumour;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.1;Tissue=Prostate Tumour;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.1;Tissue=Prostate Tumour;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.1;Tissue=Prostate Tumour;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.1;Tissue=Prostate Tumour;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.1;Tissue=Prostate Tumour;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.1;Tissue=Prostate Tumour;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.27446954;gender=male;phenotype=OBI_0000922;PreTreatment PSA=2.1;Tissue=Prostate Tumour;donor_id=CPCG0570;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10;Tissue=Prostate Tumour;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10;Tissue=Prostate Tumour;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10;Tissue=Prostate Tumour;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10;Tissue=Prostate Tumour;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10;Tissue=Prostate Tumour;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10;Tissue=Prostate Tumour;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10;Tissue=Prostate Tumour;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10;Tissue=Prostate Tumour;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10;Tissue=Prostate Tumour;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10;Tissue=Prostate Tumour;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10;Tissue=Prostate Tumour;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10;Tissue=Prostate Tumour;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10;Tissue=Prostate Tumour;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10;Tissue=Prostate Tumour;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10;Tissue=Prostate Tumour;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.45653662;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10;Tissue=Prostate Tumour;donor_id=CPCG0571;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.8;Tissue=Prostate Tumour;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.8;Tissue=Prostate Tumour;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.8;Tissue=Prostate Tumour;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.8;Tissue=Prostate Tumour;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.8;Tissue=Prostate Tumour;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.8;Tissue=Prostate Tumour;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.8;Tissue=Prostate Tumour;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.8;Tissue=Prostate Tumour;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.8;Tissue=Prostate Tumour;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.8;Tissue=Prostate Tumour;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.8;Tissue=Prostate Tumour;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.8;Tissue=Prostate Tumour;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.8;Tissue=Prostate Tumour;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.8;Tissue=Prostate Tumour;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.8;Tissue=Prostate Tumour;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.45448323;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.8;Tissue=Prostate Tumour;donor_id=CPCG0572;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Tissue=Prostate Tumour;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Tissue=Prostate Tumour;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Tissue=Prostate Tumour;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Tissue=Prostate Tumour;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Tissue=Prostate Tumour;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Tissue=Prostate Tumour;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Tissue=Prostate Tumour;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Tissue=Prostate Tumour;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Tissue=Prostate Tumour;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Tissue=Prostate Tumour;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Tissue=Prostate Tumour;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Tissue=Prostate Tumour;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Tissue=Prostate Tumour;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Tissue=Prostate Tumour;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Tissue=Prostate Tumour;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.84668036;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.8;Tissue=Prostate Tumour;donor_id=CPCG0573;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.49144422;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.4;Tissue=Prostate Tumour;donor_id=CPCG0575;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.49144422;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.4;Tissue=Prostate Tumour;donor_id=CPCG0575;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.49144422;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.4;Tissue=Prostate Tumour;donor_id=CPCG0575;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.49144422;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.4;Tissue=Prostate Tumour;donor_id=CPCG0575;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.49144422;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.4;Tissue=Prostate Tumour;donor_id=CPCG0575;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.49144422;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.4;Tissue=Prostate Tumour;donor_id=CPCG0575;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.49144422;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.4;Tissue=Prostate Tumour;donor_id=CPCG0575;ENA-CHECKLIST=ERC000026;
Age at Treatment=58.49144422;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.4;Tissue=Prostate Tumour;donor_id=CPCG0575;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.91512663;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.6;Tissue=Prostate Tumour;donor_id=CPCG0576;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.91512663;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.6;Tissue=Prostate Tumour;donor_id=CPCG0576;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.91512663;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.6;Tissue=Prostate Tumour;donor_id=CPCG0576;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.91512663;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.6;Tissue=Prostate Tumour;donor_id=CPCG0576;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.91512663;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.6;Tissue=Prostate Tumour;donor_id=CPCG0576;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.91512663;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.6;Tissue=Prostate Tumour;donor_id=CPCG0576;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.91512663;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.6;Tissue=Prostate Tumour;donor_id=CPCG0576;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.91512663;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.6;Tissue=Prostate Tumour;donor_id=CPCG0576;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.75770021;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13;Tissue=Prostate Tumour;donor_id=CPCG0577;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.75770021;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13;Tissue=Prostate Tumour;donor_id=CPCG0577;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.75770021;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13;Tissue=Prostate Tumour;donor_id=CPCG0577;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.75770021;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13;Tissue=Prostate Tumour;donor_id=CPCG0577;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.75770021;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13;Tissue=Prostate Tumour;donor_id=CPCG0577;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.75770021;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13;Tissue=Prostate Tumour;donor_id=CPCG0577;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.75770021;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13;Tissue=Prostate Tumour;donor_id=CPCG0577;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.75770021;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13;Tissue=Prostate Tumour;donor_id=CPCG0577;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.95345654;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.5;Tissue=Prostate Tumour;donor_id=CPCG0578;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.95345654;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.5;Tissue=Prostate Tumour;donor_id=CPCG0578;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.95345654;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.5;Tissue=Prostate Tumour;donor_id=CPCG0578;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.95345654;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.5;Tissue=Prostate Tumour;donor_id=CPCG0578;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.95345654;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.5;Tissue=Prostate Tumour;donor_id=CPCG0578;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.95345654;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.5;Tissue=Prostate Tumour;donor_id=CPCG0578;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.95345654;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.5;Tissue=Prostate Tumour;donor_id=CPCG0578;ENA-CHECKLIST=ERC000026;
Age at Treatment=63.95345654;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.5;Tissue=Prostate Tumour;donor_id=CPCG0578;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.14989733;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.2;Tissue=Prostate Tumour;donor_id=CPCG0580;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.14989733;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.2;Tissue=Prostate Tumour;donor_id=CPCG0580;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.14989733;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.2;Tissue=Prostate Tumour;donor_id=CPCG0580;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.14989733;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.2;Tissue=Prostate Tumour;donor_id=CPCG0580;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.14989733;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.2;Tissue=Prostate Tumour;donor_id=CPCG0580;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.14989733;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.2;Tissue=Prostate Tumour;donor_id=CPCG0580;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.14989733;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.2;Tissue=Prostate Tumour;donor_id=CPCG0580;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.14989733;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.2;Tissue=Prostate Tumour;donor_id=CPCG0580;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.14989733;gender=male;phenotype=OBI_0000922;PreTreatment PSA=3.2;Tissue=Prostate Tumour;donor_id=CPCG0580;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.93360712;gender=male;phenotype=OBI_0000922;PreTreatment PSA=12.5;Tissue=Prostate Tumour;donor_id=CPCG0581;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.93360712;gender=male;phenotype=OBI_0000922;PreTreatment PSA=12.5;Tissue=Prostate Tumour;donor_id=CPCG0581;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.93360712;gender=male;phenotype=OBI_0000922;PreTreatment PSA=12.5;Tissue=Prostate Tumour;donor_id=CPCG0581;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.93360712;gender=male;phenotype=OBI_0000922;PreTreatment PSA=12.5;Tissue=Prostate Tumour;donor_id=CPCG0581;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.93360712;gender=male;phenotype=OBI_0000922;PreTreatment PSA=12.5;Tissue=Prostate Tumour;donor_id=CPCG0581;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.93360712;gender=male;phenotype=OBI_0000922;PreTreatment PSA=12.5;Tissue=Prostate Tumour;donor_id=CPCG0581;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.93360712;gender=male;phenotype=OBI_0000922;PreTreatment PSA=12.5;Tissue=Prostate Tumour;donor_id=CPCG0581;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.93360712;gender=male;phenotype=OBI_0000922;PreTreatment PSA=12.5;Tissue=Prostate Tumour;donor_id=CPCG0581;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.93360712;gender=male;phenotype=OBI_0000922;PreTreatment PSA=12.5;Tissue=Prostate Tumour;donor_id=CPCG0581;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.68925394;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.2;Tissue=Prostate Tumour;donor_id=CPCG0582;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.68925394;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.2;Tissue=Prostate Tumour;donor_id=CPCG0582;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.68925394;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.2;Tissue=Prostate Tumour;donor_id=CPCG0582;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.68925394;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.2;Tissue=Prostate Tumour;donor_id=CPCG0582;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.68925394;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.2;Tissue=Prostate Tumour;donor_id=CPCG0582;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.68925394;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.2;Tissue=Prostate Tumour;donor_id=CPCG0582;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.68925394;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.2;Tissue=Prostate Tumour;donor_id=CPCG0582;ENA-CHECKLIST=ERC000026;
Age at Treatment=69.68925394;gender=male;phenotype=OBI_0000922;PreTreatment PSA=13.2;Tissue=Prostate Tumour;donor_id=CPCG0582;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.03080082;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.6;Tissue=Prostate Tumour;donor_id=CPCG0584;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.03080082;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.6;Tissue=Prostate Tumour;donor_id=CPCG0584;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.03080082;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.6;Tissue=Prostate Tumour;donor_id=CPCG0584;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.03080082;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.6;Tissue=Prostate Tumour;donor_id=CPCG0584;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.03080082;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.6;Tissue=Prostate Tumour;donor_id=CPCG0584;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.03080082;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.6;Tissue=Prostate Tumour;donor_id=CPCG0584;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.03080082;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.6;Tissue=Prostate Tumour;donor_id=CPCG0584;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.03080082;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.6;Tissue=Prostate Tumour;donor_id=CPCG0584;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.03080082;gender=male;phenotype=OBI_0000922;PreTreatment PSA=5.6;Tissue=Prostate Tumour;donor_id=CPCG0584;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.69130732;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.4;Tissue=Prostate Tumour;donor_id=CPCG0587;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.69130732;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.4;Tissue=Prostate Tumour;donor_id=CPCG0587;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.69130732;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.4;Tissue=Prostate Tumour;donor_id=CPCG0587;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.69130732;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.4;Tissue=Prostate Tumour;donor_id=CPCG0587;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.69130732;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.4;Tissue=Prostate Tumour;donor_id=CPCG0587;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.69130732;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.4;Tissue=Prostate Tumour;donor_id=CPCG0587;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.69130732;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.4;Tissue=Prostate Tumour;donor_id=CPCG0587;ENA-CHECKLIST=ERC000026;
Age at Treatment=70.69130732;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.4;Tissue=Prostate Tumour;donor_id=CPCG0587;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.05407255;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.3;Tissue=Prostate Tumour;donor_id=CPCG0588;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.05407255;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.3;Tissue=Prostate Tumour;donor_id=CPCG0588;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.05407255;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.3;Tissue=Prostate Tumour;donor_id=CPCG0588;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.05407255;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.3;Tissue=Prostate Tumour;donor_id=CPCG0588;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.05407255;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.3;Tissue=Prostate Tumour;donor_id=CPCG0588;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.05407255;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.3;Tissue=Prostate Tumour;donor_id=CPCG0588;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.05407255;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.3;Tissue=Prostate Tumour;donor_id=CPCG0588;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.05407255;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.3;Tissue=Prostate Tumour;donor_id=CPCG0588;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.14373717;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.9;Tissue=Prostate Tumour;donor_id=CPCG0590;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.14373717;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.9;Tissue=Prostate Tumour;donor_id=CPCG0590;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.14373717;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.9;Tissue=Prostate Tumour;donor_id=CPCG0590;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.14373717;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.9;Tissue=Prostate Tumour;donor_id=CPCG0590;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.14373717;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.9;Tissue=Prostate Tumour;donor_id=CPCG0590;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.14373717;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.9;Tissue=Prostate Tumour;donor_id=CPCG0590;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.14373717;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.9;Tissue=Prostate Tumour;donor_id=CPCG0590;ENA-CHECKLIST=ERC000026;
Age at Treatment=66.14373717;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.9;Tissue=Prostate Tumour;donor_id=CPCG0590;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.59685147;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.1;Tissue=Prostate Tumour;donor_id=CPCG0591;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.59685147;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.1;Tissue=Prostate Tumour;donor_id=CPCG0591;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.59685147;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.1;Tissue=Prostate Tumour;donor_id=CPCG0591;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.59685147;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.1;Tissue=Prostate Tumour;donor_id=CPCG0591;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.59685147;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.1;Tissue=Prostate Tumour;donor_id=CPCG0591;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.59685147;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.1;Tissue=Prostate Tumour;donor_id=CPCG0591;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.59685147;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.1;Tissue=Prostate Tumour;donor_id=CPCG0591;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.59685147;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.1;Tissue=Prostate Tumour;donor_id=CPCG0591;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.99383984;gender=male;phenotype=OBI_0000922;PreTreatment PSA=15;Tissue=Prostate Tumour;donor_id=CPCG0593;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.99383984;gender=male;phenotype=OBI_0000922;PreTreatment PSA=15;Tissue=Prostate Tumour;donor_id=CPCG0593;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.99383984;gender=male;phenotype=OBI_0000922;PreTreatment PSA=15;Tissue=Prostate Tumour;donor_id=CPCG0593;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.99383984;gender=male;phenotype=OBI_0000922;PreTreatment PSA=15;Tissue=Prostate Tumour;donor_id=CPCG0593;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.99383984;gender=male;phenotype=OBI_0000922;PreTreatment PSA=15;Tissue=Prostate Tumour;donor_id=CPCG0593;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.99383984;gender=male;phenotype=OBI_0000922;PreTreatment PSA=15;Tissue=Prostate Tumour;donor_id=CPCG0593;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.99383984;gender=male;phenotype=OBI_0000922;PreTreatment PSA=15;Tissue=Prostate Tumour;donor_id=CPCG0593;ENA-CHECKLIST=ERC000026;
Age at Treatment=64.99383984;gender=male;phenotype=OBI_0000922;PreTreatment PSA=15;Tissue=Prostate Tumour;donor_id=CPCG0593;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.68651608;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.7;Tissue=Prostate Tumour;donor_id=CPCG0595;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.68651608;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.7;Tissue=Prostate Tumour;donor_id=CPCG0595;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.68651608;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.7;Tissue=Prostate Tumour;donor_id=CPCG0595;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.68651608;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.7;Tissue=Prostate Tumour;donor_id=CPCG0595;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.68651608;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.7;Tissue=Prostate Tumour;donor_id=CPCG0595;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.68651608;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.7;Tissue=Prostate Tumour;donor_id=CPCG0595;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.68651608;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.7;Tissue=Prostate Tumour;donor_id=CPCG0595;ENA-CHECKLIST=ERC000026;
Age at Treatment=53.68651608;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.7;Tissue=Prostate Tumour;donor_id=CPCG0595;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.67008898;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.4;Tissue=Prostate Tumour;donor_id=CPCG0596;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.67008898;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.4;Tissue=Prostate Tumour;donor_id=CPCG0596;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.67008898;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.4;Tissue=Prostate Tumour;donor_id=CPCG0596;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.67008898;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.4;Tissue=Prostate Tumour;donor_id=CPCG0596;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.67008898;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.4;Tissue=Prostate Tumour;donor_id=CPCG0596;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.67008898;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.4;Tissue=Prostate Tumour;donor_id=CPCG0596;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.67008898;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.4;Tissue=Prostate Tumour;donor_id=CPCG0596;ENA-CHECKLIST=ERC000026;
Age at Treatment=61.67008898;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.4;Tissue=Prostate Tumour;donor_id=CPCG0596;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.66872005;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.4;Tissue=Prostate Tumour;donor_id=CPCG0597;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.66872005;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.4;Tissue=Prostate Tumour;donor_id=CPCG0597;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.66872005;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.4;Tissue=Prostate Tumour;donor_id=CPCG0597;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.66872005;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.4;Tissue=Prostate Tumour;donor_id=CPCG0597;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.66872005;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.4;Tissue=Prostate Tumour;donor_id=CPCG0597;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.66872005;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.4;Tissue=Prostate Tumour;donor_id=CPCG0597;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.66872005;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.4;Tissue=Prostate Tumour;donor_id=CPCG0597;ENA-CHECKLIST=ERC000026;
Age at Treatment=67.66872005;gender=male;phenotype=OBI_0000922;PreTreatment PSA=7.4;Tissue=Prostate Tumour;donor_id=CPCG0597;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.79534565;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.7;Tissue=Prostate Tumour;donor_id=CPCG0598;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.79534565;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.7;Tissue=Prostate Tumour;donor_id=CPCG0598;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.79534565;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.7;Tissue=Prostate Tumour;donor_id=CPCG0598;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.79534565;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.7;Tissue=Prostate Tumour;donor_id=CPCG0598;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.79534565;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.7;Tissue=Prostate Tumour;donor_id=CPCG0598;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.79534565;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.7;Tissue=Prostate Tumour;donor_id=CPCG0598;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.79534565;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.7;Tissue=Prostate Tumour;donor_id=CPCG0598;ENA-CHECKLIST=ERC000026;
Age at Treatment=62.79534565;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.7;Tissue=Prostate Tumour;donor_id=CPCG0598;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.26283368;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.5;Tissue=Prostate Tumour;donor_id=CPCG0599;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.26283368;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.5;Tissue=Prostate Tumour;donor_id=CPCG0599;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.26283368;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.5;Tissue=Prostate Tumour;donor_id=CPCG0599;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.26283368;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.5;Tissue=Prostate Tumour;donor_id=CPCG0599;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.26283368;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.5;Tissue=Prostate Tumour;donor_id=CPCG0599;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.26283368;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.5;Tissue=Prostate Tumour;donor_id=CPCG0599;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.26283368;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.5;Tissue=Prostate Tumour;donor_id=CPCG0599;ENA-CHECKLIST=ERC000026;
Age at Treatment=68.26283368;gender=male;phenotype=OBI_0000922;PreTreatment PSA=10.5;Tissue=Prostate Tumour;donor_id=CPCG0599;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.95893224;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.4;Tissue=Prostate Tumour;donor_id=CPCG0600;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.95893224;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.4;Tissue=Prostate Tumour;donor_id=CPCG0600;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.95893224;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.4;Tissue=Prostate Tumour;donor_id=CPCG0600;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.95893224;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.4;Tissue=Prostate Tumour;donor_id=CPCG0600;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.95893224;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.4;Tissue=Prostate Tumour;donor_id=CPCG0600;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.95893224;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.4;Tissue=Prostate Tumour;donor_id=CPCG0600;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.95893224;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.4;Tissue=Prostate Tumour;donor_id=CPCG0600;ENA-CHECKLIST=ERC000026;
Age at Treatment=55.95893224;gender=male;phenotype=OBI_0000922;PreTreatment PSA=9.4;Tissue=Prostate Tumour;donor_id=CPCG0600;ENA-CHECKLIST=ERC000026;
Age at Treatment=57.51676934;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.9;Tissue=Prostate Tumour;donor_id=CPCG0601;ENA-CHECKLIST=ERC000026;
Age at Treatment=57.51676934;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.9;Tissue=Prostate Tumour;donor_id=CPCG0601;ENA-CHECKLIST=ERC000026;
Age at Treatment=57.51676934;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.9;Tissue=Prostate Tumour;donor_id=CPCG0601;ENA-CHECKLIST=ERC000026;
Age at Treatment=57.51676934;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.9;Tissue=Prostate Tumour;donor_id=CPCG0601;ENA-CHECKLIST=ERC000026;
Age at Treatment=57.51676934;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.9;Tissue=Prostate Tumour;donor_id=CPCG0601;ENA-CHECKLIST=ERC000026;
Age at Treatment=57.51676934;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.9;Tissue=Prostate Tumour;donor_id=CPCG0601;ENA-CHECKLIST=ERC000026;
Age at Treatment=57.51676934;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.9;Tissue=Prostate Tumour;donor_id=CPCG0601;ENA-CHECKLIST=ERC000026;
Age at Treatment=57.51676934;gender=male;phenotype=OBI_0000922;PreTreatment PSA=8.9;Tissue=Prostate Tumour;donor_id=CPCG0601;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.29021218;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.5;Tissue=Prostate Tumour;donor_id=CPCG0604;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.29021218;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.5;Tissue=Prostate Tumour;donor_id=CPCG0604;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.29021218;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.5;Tissue=Prostate Tumour;donor_id=CPCG0604;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.29021218;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.5;Tissue=Prostate Tumour;donor_id=CPCG0604;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.29021218;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.5;Tissue=Prostate Tumour;donor_id=CPCG0604;ENA-CHECKLIST=ERC000026;
Age at Treatment=60.29021218;gender=male;phenotype=OBI_0000922;PreTreatment PSA=6.5;Tissue=Prostate Tumour;donor_id=CPCG0604;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.70978782;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.7;Tissue=Prostate Tumour;donor_id=CPCG0605;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.70978782;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.7;Tissue=Prostate Tumour;donor_id=CPCG0605;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.70978782;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.7;Tissue=Prostate Tumour;donor_id=CPCG0605;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.70978782;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.7;Tissue=Prostate Tumour;donor_id=CPCG0605;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.70978782;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.7;Tissue=Prostate Tumour;donor_id=CPCG0605;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.70978782;gender=male;phenotype=OBI_0000922;PreTreatment PSA=4.7;Tissue=Prostate Tumour;donor_id=CPCG0605;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.38398357;gender=male;phenotype=OBI_0000922;PreTreatment PSA=18.7;Tissue=Prostate Tumour;donor_id=CPCG0606;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.38398357;gender=male;phenotype=OBI_0000922;PreTreatment PSA=18.7;Tissue=Prostate Tumour;donor_id=CPCG0606;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.38398357;gender=male;phenotype=OBI_0000922;PreTreatment PSA=18.7;Tissue=Prostate Tumour;donor_id=CPCG0606;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.38398357;gender=male;phenotype=OBI_0000922;PreTreatment PSA=18.7;Tissue=Prostate Tumour;donor_id=CPCG0606;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.38398357;gender=male;phenotype=OBI_0000922;PreTreatment PSA=18.7;Tissue=Prostate Tumour;donor_id=CPCG0606;ENA-CHECKLIST=ERC000026;
Age at Treatment=59.38398357;gender=male;phenotype=OBI_0000922;PreTreatment PSA=18.7;Tissue=Prostate Tumour;donor_id=CPCG0606;ENA-CHECKLIST=ERC000026;
